{"study_id": 52989, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the performance of three different heated humidifiers for gas conditioning during helmet continuous positive airway pressure (CPAP) and compare them to a setting without active humidification.", "results_summary": "Without active humidification, absolute humidity remained below recommended levels, while all three humidifiers achieved adequate conditioning (absolute humidity >10 mg H2O/L). The H900 humidifier performed best, followed by TurbH2O and F&P 810, with statistically significant differences.", "population_specificity": "Healthy volunteers", "effective_dosage": "Not specified", "study_duration": "Measurements taken at 1, 5, and 10 minutes", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:57.646618+00:00"}
{"study_id": 52988, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the benefits, efficacy, and parental experiences of Hypoglossal Nerve Stimulator (HNS) use in children with Down Syndrome (DS) and persistent obstructive sleep apnea (OSA) after adenotonsillectomy and continuous positive airway pressure (CPAP) treatment.", "results_summary": "The study found that HNS implantation in children with DS and persistent OSA significantly improved polysomnographic outcomes, quality of life scores, and neurocognitive measures, with high compliance rates. The findings suggest HNS is a promising treatment for this population.", "population_specificity": "Pediatric patients under 21 years old with Down Syndrome and persistent OSA after adenotonsillectomy and CPAP trials.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:58.370420+00:00"}
{"study_id": 52987, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether an individualized open-lung approach (iOLA) ventilation strategy reduces postoperative pulmonary complications compared to standard lung-protective ventilation in patients undergoing thoracic surgery with one-lung ventilation.", "results_summary": "The study found that iOLA significantly reduced the risk of severe postoperative pulmonary complications within the first 7 postoperative days (6% vs. 15% in the standard group), with a relative risk of 0.39. Adverse events related to the recruitment maneuver were rare, occurring in only five patients.", "population_specificity": "Adult patients (age \u226518 years) undergoing open or video-assisted thoracic surgery with one-lung ventilation across 25 hospitals in Spain, Italy, Turkey, Egypt, and Ecuador.", "effective_dosage": "Alveolar recruitment maneuver to 40 cm H\u2082O (specific frequency not detailed).", "study_duration": "Intervention administered perioperatively (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:59.112735+00:00"}
{"study_id": 52990, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to quantify the variability in definitions of sleep apnea indices (apnea, hypopnea, and oxygen desaturation) across clinical studies of Continuous Positive Airway Pressure (CPAP).", "results_summary": "The study found significant variability in how sleep apnea indices were defined across 57 studies, with inconsistencies in thresholds for airflow cessation and oxygen desaturation. This lack of standardization and transparency hampers the interpretability and generalizability of CPAP studies.", "population_specificity": "Not specified (analysis of 57 comparative studies on CPAP's long-term clinical outcomes).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:01.447659+00:00"}
{"study_id": 52991, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the therapeutic outcomes of Iranian surfactant (beraksurf) and BLES on RDS treatment among preterm neonates, including the use of non-invasive continuous positive airway pressure (CPAP).", "results_summary": "The study found that beraksurf and BLES had similar efficacy for treating RDS in preterm infants, with comparable short-term outcomes. Beraksurf showed lower risk ratios for complications like pneumothorax and pulmonary hemorrhage, but no significant difference in mortality.", "population_specificity": "Preterm neonates (gestational age 28-34 weeks, weight \u22651 kg) diagnosed with RDS in a hospital in Kerman, Iran.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:02.592904+00:00"}
{"study_id": 52993, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate how changes in respiratory support practices, including the timing of surfactant administration, impact mortality and morbidity in preterm infants with RDS.", "results_summary": "The study highlights that early surfactant administration improves outcomes in preterm infants with RDS, and non-invasive respiratory support methods have become more prevalent. The review synthesizes evidence on how these practice changes affect surfactant timing's efficacy.", "population_specificity": "Preterm infants with respiratory distress syndrome (RDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:03.068522+00:00"}
{"study_id": 52994, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of nCPAP and HFNC versus usual care in reducing pulmonary infection, endotracheal intubation, and improving neurological function and sleep apnea severity in patients with sleep apnea after acute ischemic stroke.", "results_summary": "Both nCPAP and HFNC were more effective than usual care in reducing pulmonary infection and endotracheal intubation rates and improving neurological function and sleep apnea severity, with no difference in 28-day mortality. HFNC was superior to nCPAP in terms of patient comfort.", "population_specificity": "Patients diagnosed with sleep apnea after acute ischemic stroke (mean age 61.04 years, 66.85% male).", "effective_dosage": "Not specified", "study_duration": "1 week of hospitalization (primary outcomes), with 28-day mortality follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:05.365483+00:00"}
{"study_id": 52995, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the role of Continuous Positive Airway Pressure (CPAP) in managing obstructive sleep apnea (OSA), particularly its safety and efficacy in perioperative settings for nasal, sinus, and skull base surgery.", "results_summary": "CPAP therapy remains the first-line medical treatment for OSA, improving sleep quality and compliance. Nasal surgery enhances CPAP tolerance and usage, though perioperative CPAP resumption timing depends on patient and surgical factors.", "population_specificity": "Patients with obstructive sleep apnea (OSA), particularly those undergoing nasal, sinus, or skull base surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:06.948178+00:00"}
{"study_id": 52968, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine if higher nCPAP levels compared to standard nCPAP levels would reduce extubation failure rates in extremely preterm infants within 7 days of their first extubation.", "results_summary": "Higher nCPAP levels significantly reduced extubation failure (35% vs. 57%) compared to standard nCPAP, with no significant differences in adverse event rates between groups. The study concluded that higher nCPAP is effective and safe for this population.", "population_specificity": "Extremely preterm infants (born at less than 28 weeks gestation).", "effective_dosage": "Higher nCPAP (10 cmH\u2082O) vs. standard nCPAP (7 cmH\u2082O).", "study_duration": "7 days post-extubation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:07.460169+00:00"}
{"study_id": 52997, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to discuss controversies in OSA management, including CPAP therapy's role and limitations, and explore surgical alternatives.", "results_summary": "CPAP is considered the gold standard for moderate to severe OSA but has low adherence rates, and its efficacy beyond symptom reduction and quality of life improvement is uncertain. Surgical intervention may be an alternative for specific patients.", "population_specificity": "Patients with obstructive sleep apnea (OSA), particularly those with moderate to severe cases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:07.529130+00:00"}
{"study_id": 52996, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop and operationalize a core inpatient dataset to track outcomes and improve quality of care for small and sick newborns, including those receiving Continuous Positive Airway Pressure (CPAP), in high-mortality settings.", "results_summary": "The study co-designed a Neonatal Inpatient Dataset (NID) with 60 core variables, implemented across 69 neonatal units in four African countries, linking to a real-time quality improvement dashboard to enhance SSNC quality and progress toward ENAP targets.", "population_specificity": "Small and sick newborns in high-mortality settings (Malawi, Kenya, Tanzania, and Nigeria).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:07.733004+00:00"}
{"study_id": 52998, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether CPAP improves bronchoalveolar lavage (BAL) salvage in patients with interstitial lung disease (ILD) or chronic obstructive pulmonary disease (COPD).", "results_summary": "The abstract does not provide results, as the study is prospective and ongoing. The trial will assess BAL volume and content, as well as predictors of low BAL recovery.", "population_specificity": "300 patients (150 with ILD and 150 with COPD) with initial BAL salvage <60%.", "effective_dosage": "Not specified (CPAP settings will follow the study protocol).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:10.659196+00:00"}
{"study_id": 52999, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether using lung ultrasound scores (LUS) could reduce the time to administer surfactant therapy in preterm infants with respiratory distress syndrome (RDS) managed with Continuous Positive Airway Pressure (CPAP).", "results_summary": "The study suggests that LUS may decrease the time to administer surfactant therapy, potentially reducing bronchopulmonary dysplasia (BPD) or death, as early surfactant administration is known to lower BPD and mortality.", "population_specificity": "Preterm infants born at 25-33 weeks gestation with RDS managed on CPAP.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:11.282936+00:00"}
{"study_id": 53000, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to investigate CPAP adherence among individuals with OSA and MCI/AD to understand its potential role in slowing cognitive decline.", "results_summary": "Around half of participants with MCI/AD were adherent to CPAP (\u22654 h/night), with average use ranging between 3.2 and 6.3 h/night. Adherence rates were low but similar to the general elderly population.", "population_specificity": "Individuals with obstructive sleep apnoea (OSA) and mild cognitive impairment (MCI) or Alzheimer's disease (AD), mean age 72.1 years.", "effective_dosage": "\u22654 h/night considered adherent", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:12.439113+00:00"}
{"study_id": 53002, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of Continuous Positive Airway Pressure (CPAP) with other pharmacologic and interventional treatments for reducing blood pressure in patients with resistant hypertension.", "results_summary": "CPAP was analyzed as one of the treatment alternatives, but the abstract does not provide specific efficacy data for CPAP compared to other treatments. Spironolactone was identified as the most effective treatment, while lifestyle interventions were the most effective non-pharmacological option.", "population_specificity": "Patients with resistant hypertension.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:15.040930+00:00"}
{"study_id": 53003, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the feasibility of a nurse practitioner-led virtual intervention (MENDS) to improve CPAP adherence in adults with Obstructive Sleep Apnea (OSA) and compare changes in adherence to patient-reported outcomes.", "results_summary": "The MENDS intervention was feasible, with high session completion and minimal attrition. Higher CPAP adherence and lower AHI levels were associated with improvements in fatigue, sleep disturbance, and anxiety, though no significant time-by-group interactions were found.", "population_specificity": "Adults newly diagnosed with OSA and prescribed CPAP therapy.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:16.140805+00:00"}
{"study_id": 53004, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to measure the average time for diagnosis and therapeutic prescription of CPAP at a hospital in Botucatu Medical School, assessing the efficiency of the diagnostic-therapeutic flow.", "results_summary": "The study found long waiting periods (mean 624 days from referral to CPAP prescription), high dropout rates (64.1% of referred patients did not acquire CPAP), and inefficient access to treatment, highlighting systemic inefficiencies.", "population_specificity": "Patients over 18-years-old with scheduled diagnostic polysomnography at Botucatu Medical School in 2017.", "effective_dosage": "Not specified", "study_duration": "Not specified (retrospective observational study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:16.938853+00:00"}
{"study_id": 53005, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the existing literature on the treatment effects of OSA, particularly CPAP, on cardiovascular disease morbidity and mortality, stratified by gender.", "results_summary": "CPAP was associated with a reduction in CVD mortality in 4 studies and improvement in morbidity in 10 studies, but the review did not show consistent benefits in CV outcomes for OSA patients.", "population_specificity": "Adults aged 45-75 years with obstructive sleep apnea, predominantly male (60%-90%).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:17.014726+00:00"}
{"study_id": 53007, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of high-flow nasal cannula (HFNC) therapy across different diseases and intervention types in paediatric patients.", "results_summary": "The study found that HFNC therapy is predominantly effective, particularly for acute lower respiratory infection, hypoxaemia, bronchiolitis, and post-extubation respiratory distress syndrome, with significant benefits in respiratory support.", "population_specificity": "Paediatric patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:20.358875+00:00"}
{"study_id": 53006, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the use of Continuous Positive Airway Pressure (CPAP) across COVID-19 waves and assess its role in respiratory support and patient outcomes.", "results_summary": "CPAP was the primary respiratory support during the first wave, but its use decreased in later waves with increased adoption of high-flow nasal cannula and non-invasive ventilation, leading to improved discharge rates and reduced intubation. Vaccinated patients showed better outcomes, including less severe respiratory failure.", "population_specificity": "COVID-19 patients admitted to a Pneumology Department across three pandemic waves (March 2020\u2013March 2022).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:20.969915+00:00"}
{"study_id": 53010, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) in avoiding positive pressure ventilation and its potential impact on delaying surfactant administration in preterm infants with respiratory distress syndrome (RDS).", "results_summary": "CPAP as primary respiratory support can avoid positive pressure ventilation in many cases but may delay surfactant administration. Alternative surfactant delivery methods were discussed to combine the benefits of surfactant therapy with CPAP use.", "population_specificity": "Preterm infants at risk for bronchopulmonary dysplasia (BPD) and respiratory distress syndrome (RDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:23.495427+00:00"}
{"study_id": 53011, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of a mandibular advancement device (MAD) in treating mild to moderate obstructive sleep apnea and assess changes in upper airway space volume using CBCT.", "results_summary": "The study found a statistically significant increase in upper airway space volume (from 7.77\u00b12.79 cc to 9.75\u00b13.34 cc) after MAD treatment, along with patient-reported improvements in sleep quality and symptom reduction.", "population_specificity": "Patients with mild to moderate obstructive sleep apnea identified using the Berlin questionnaire.", "effective_dosage": "Not specified", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:24.348207+00:00"}
{"study_id": 53012, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the clinical efficacy of HFNC, CPAP, and NIPPV as primary noninvasive ventilation in neonates \u226532 weeks' gestational age with respiratory distress.", "results_summary": "The abstract does not provide specific results for CPAP, as the study is ongoing and outcomes like treatment failure, safety, and comfort are yet to be evaluated.", "population_specificity": "Neonates \u226532 weeks' gestational age requiring primary noninvasive ventilation within the first 24 hours of life.", "effective_dosage": "Not specified", "study_duration": "Outcomes assessed within 72 hours after enrollment, but intervention duration not explicitly stated.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:25.340702+00:00"}
{"study_id": 53013, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of different noninvasive respiratory support techniques, including CPAP, in preventing postoperative pulmonary complications in obese patients.", "results_summary": "CPAP was found to be superior to other techniques in improving oxygenation but showed no significant difference in reducing other postoperative pulmonary complications compared to COT, BiPAP, or HFNC. HFNC ranked highest in most outcomes, including reducing hypoxemia and shortening hospital stays.", "population_specificity": "Obese patients undergoing general anesthesia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:25.377413+00:00"}
{"study_id": 53001, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the feasibility of an RCT evaluating oropharyngeal exercises as an alternative therapy for OSA in stroke/TIA patients who poorly tolerate CPAP.", "results_summary": "The study found that oropharyngeal exercises improved tongue pressures, reduced OSA severity (measured by AHI and ODI), decreased daytime sleepiness, and enhanced quality of life, with some effects persisting at follow-up.", "population_specificity": "Stroke or transient ischaemic attack (TIA) patients with obstructive sleep apnea (OSA) who could not tolerate CPAP.", "effective_dosage": "30 minutes twice per day, 5 days per week.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:25.549992+00:00"}
{"study_id": 53014, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of low versus high anticoagulation regimens in hospitalized severe COVID-19 patients with respiratory compromise and/or coagulopathy.", "results_summary": "The abstract does not provide specific results regarding Continuous Positive Airway Pressure, as the focus was on anticoagulant regimens.", "population_specificity": "Hospitalized severe COVID-19 patients with respiratory compromise and/or coagulopathy.", "effective_dosage": "Low (4000 IU qd) or high (70 IU/kg) anticoagulant regimens.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:29.881280+00:00"}
{"study_id": 53016, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to assess the effect of CPAP treatment for obstructive sleep apnea on the risk of adverse cardiovascular events in randomized clinical trials.", "results_summary": "The study found no significant difference in major adverse cardiac and cerebrovascular events (MACCEs) between CPAP and no CPAP groups overall, but good adherence to CPAP (\u22654 hours per day) was associated with a reduced risk of MACCEs.", "population_specificity": "Adults with cardiovascular disease and obstructive sleep apnea (82.1% men; mean age 61.2 years; mean BMI 28.9).", "effective_dosage": "Mean adherence was 3.1 hours per day, with good adherence defined as \u22654 hours per day.", "study_duration": "Mean follow-up of 3.25 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:30.642646+00:00"}
{"study_id": 53017, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to test whether morning bright light therapy (BLT) could improve sleep, circadian rhythms, and CPAP-resistant daytime symptoms in patients with sleep apnea.", "results_summary": "BLT reduced wake after sleep onset and increased rest-activity rhythm amplitude compared to sham treatment. Patients also reported reduced sleepiness and depressive symptoms with BLT, though these effects were observed primarily in early treatment stages and shorter photoperiods.", "population_specificity": "14 individuals with sleep apnea experiencing residual symptoms despite CPAP treatment.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:33.378967+00:00"}
{"study_id": 53019, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify early factors associated with CPAP failure in moderate-to-late preterm infants with respiratory distress.", "results_summary": "CPAP failure occurred in 12% of infants, with higher rates in singletons, those with lower Apgar scores at 10 minutes, and those requiring higher FiO\u2082. The study suggests these factors may predict CPAP failure.", "population_specificity": "Moderate-to-late preterm infants (32+0/7 to 36+6/7 weeks' gestation) with respiratory distress requiring CPAP within the first 24 hours of life.", "effective_dosage": "Not specified", "study_duration": "CPAP was administered for up to 72 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:34.472600+00:00"}
{"study_id": 53018, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether prophylactic LISA treatment in preterm infants on continuous positive airway pressure (CPAP) with \u226430% supplemental oxygen improves long-term respiratory outcomes compared to CPAP alone.", "results_summary": "The study is ongoing, so no results are reported yet; it will compare forced expiratory volume at age 5 between intervention (LISA + CPAP) and control (CPAP only) groups, along with secondary outcomes like lung function and neurodevelopment.", "population_specificity": "Preterm infants (25\u201328 weeks\u2019 gestation) breathing spontaneously on CPAP with \u226430% supplemental oxygen in the first hour of life.", "effective_dosage": "100\u2013200 mg surfactant intratracheally per kilogram bodyweight (single dose).", "study_duration": "Follow-up until age 5 years; intervention duration not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:34.681532+00:00"}
{"study_id": 53020, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to synthesize evidence on MRI biomarkers and neuropsychological assessments of attention deficits in OSA patients and evaluate the effects of Continuous Positive Airway Pressure (CPAP) on brain changes and cognitive function.", "results_summary": "The study found that OSA is associated with structural, functional, and metabolic brain alterations in attention-related regions, and CPAP treatment can partially reverse some of these changes and improve cognitive function in certain domains.", "population_specificity": "Patients with obstructive sleep apnea (OSA)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:34.685099+00:00"}
{"study_id": 53021, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Mandibular Repositioning Appliances (MRDs) as an alternative to Continuous Positive Airway Pressure (CPAP) in improving the Oxygen Desaturation Index (ODI) and Epworth Sleepiness Scale (ESS) in OSA patients.", "results_summary": "The study found that MRDs significantly improved ODI (from 10.68 to 6.58) and ESS (from 9.46 to 6.02) in OSA patients, suggesting MRDs are an effective alternative to CPAP for specific OSA phenotypes.", "population_specificity": "138 patients (91 men, 47 women; mean age: 49.49 \u00b1 11.93 years) diagnosed with OSA in an NHS hospital respiratory clinic.", "effective_dosage": "Not specified", "study_duration": "6-8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:35.429595+00:00"}
{"study_id": 53022, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare clinical characteristics and outcomes (H-CPAP success/failure and survival/death) in COVID-19 ARDS patients and identify predictors of H-CPAP success and survival.", "results_summary": "The study enrolled 515 COVID-19 ARDS patients treated with H-CPAP in RICU settings, evaluating outcomes across three pandemic waves, but specific efficacy results are not detailed in the abstract.", "population_specificity": "COVID-19 patients with Acute Respiratory Distress Syndrome (CARDS) treated in respiratory intermediate care units (RICU).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:38.983433+00:00"}
{"study_id": 53023, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess whether hypoxic burden (HB) could predict the cardiovascular benefits of treating obstructive sleep apnoea (OSA) with continuous positive airway pressure (CPAP).", "results_summary": "In patients with high HB, CPAP treatment significantly reduced cardiovascular events (HR 0.57), while in low HB patients, CPAP showed a trend toward higher cardiovascular risk (HR 1.33). The treatment effect varied with baseline HB levels in a dose-response manner.", "population_specificity": "Middle-aged (mean 59.7 years), overweight/obese, mostly male (84.5%) non-sleepy acute coronary syndrome (ACS) patients with OSA.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:40.044330+00:00"}
{"study_id": 53024, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of a novel aerosolized surfactant drug/device combination in preterm infants, alongside CPAP, to improve outcomes in respiratory distress syndrome.", "results_summary": "The abstract does not provide specific results regarding CPAP's effects, but it mentions that less invasive methods, including CPAP, have improved preterm infant outcomes. The trial focuses on aerosolized surfactant, with CPAP as a supportive measure.", "population_specificity": "Preterm infants of 27-34 weeks gestation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:41.622252+00:00"}
{"study_id": 53027, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the relationship between obstructive sleep apnea (OSA) and atrial fibrillation, focusing on the potential role of CPAP therapy in reducing atrial fibrillation recurrence and burden.", "results_summary": "The abstract notes mixed results regarding CPAP's efficacy in reducing atrial fibrillation burden, with some RCTs showing no significant effect, while one RCT indicated CPAP could attenuate the atrial substrate, potentially impacting long-term outcomes. Observational studies suggest CPAP may reduce atrial fibrillation recurrence post-ablation or cardioversion.", "population_specificity": "Patients with atrial fibrillation and obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:43.858486+00:00"}
{"study_id": 53026, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether minimally invasive surfactant therapy (MIST) compared to sham treatment reduced death or neurodevelopmental disability in preterm infants with respiratory distress syndrome supported by CPAP.", "results_summary": "MIST did not reduce death or neurodevelopmental disability by 2 years of age but was associated with lower rates of adverse respiratory outcomes, such as hospitalizations and parent-reported wheezing or breathing difficulty, compared to the control group.", "population_specificity": "Preterm infants with a gestational age of 25 to 28 weeks supported with CPAP.", "effective_dosage": "200 mg/kg poractant alfa (single administration via thin catheter).", "study_duration": "Single administration during initial treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:44.253873+00:00"}
{"study_id": 53028, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of 12 months of CPAP treatment on lumbar and femur bone mineral density (BMD) and bone-related serum biomarkers in male patients with severe obstructive sleep apnea (OSA).", "results_summary": "The study found a significant increase in BMD in the L1 region and improved bone-related serum biomarkers after 12 months of CPAP treatment, suggesting that CPAP may restore bone health in male patients with severe OSA.", "population_specificity": "Male patients with severe obstructive sleep apnea (mean age: 55.1 \u00b1 9.9 years).", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:44.624841+00:00"}
{"study_id": 53025, "supplement_id": 1048, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the impact of demographic, clinical, and technology-related factors on long-term NIV adverse events in children using continuous positive airway pressure.", "results_summary": "The study found that NIV-related complications, such as skin injury and unintentional air leaks, were frequent (93% reported at least one adverse event). Younger age and certain underlying conditions were early predictors of adverse events, while mask type was not a significant predictor.", "population_specificity": "Children in Alberta, Canada, who initiated long-term NIV between 2005 and 2014, with a median age of 7.5 years.", "effective_dosage": "Not specified", "study_duration": "Follow-up until December 2015 (median follow-up not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:45.166993+00:00"}
{"study_id": 53030, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to provide an overview of the assessment and management of comorbid insomnia and sleep apnoea, including the role of Continuous Positive Airway Pressure (CPAP) as a first-line treatment for moderate and severe obstructive sleep apnoea.", "results_summary": "The study highlights that CPAP is the recommended first-line treatment for moderate and severe obstructive sleep apnoea, alongside lifestyle/weight management advice, but does not provide specific efficacy data from the study itself.", "population_specificity": "Patients with comorbid insomnia and obstructive sleep apnoea, particularly in Australian general practice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:49.249310+00:00"}
{"study_id": 53031, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the feasibility and effectiveness of CPAP treatment in stroke patients with sleep apnea.", "results_summary": "CPAP treatment was found feasible, with a mean use of 4.47 hours per night, and may improve neurological outcomes, though results should be interpreted cautiously due to heterogeneity among trials.", "population_specificity": "Stroke or transient ischemic attack patients with sleep apnea.", "effective_dosage": "Mean CPAP use of 4.47 hours per night.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:49.263806+00:00"}
{"study_id": 53029, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effect of Continuous Positive Airway Pressure (CPAP) treatment on glycaemic control in patients with obstructive sleep apnoea and type 2 diabetes.", "results_summary": "CPAP treatment significantly reduced haemoglobin A1c (HbA1c) by 0.24% compared to inactive control groups, with meta-regression showing a dose-response relationship between HbA1c reduction and nightly CPAP usage. The study concluded that CPAP improves long-term glycaemic control in this population, with efficacy dependent on adherence.", "population_specificity": "Patients with co-existing obstructive sleep apnoea and type 2 diabetes (n=964 across 11 RCTs).", "effective_dosage": "Not specified (hours of nightly usage correlated with efficacy).", "study_duration": "Not specified (follow-up duration not detailed in abstract).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:50.491446+00:00"}
{"study_id": 53033, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy of CPAP and HFNC in reducing the risk of intubation and improving clinical outcomes for patients with acute hypoxemic respiratory failure.", "results_summary": "CPAP reduced the risk of meeting intubation criteria compared to HFNC (HR 0.327, p=0.006), with no significant differences in intubation rates, mortality, or other secondary outcomes. CPAP also improved pulmonary oxygenation but had no effect on respiratory rate.", "population_specificity": "Patients with acute hypoxemic respiratory failure.", "effective_dosage": "Not specified", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:52.469533+00:00"}
{"study_id": 53035, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential link between obstructive sleep apnea (OSA) and Alzheimer's disease (AD) pathophysiology, and whether treating OSA could impact AD biomarkers or cognitive decline.", "results_summary": "The study suggests OSA is associated with cognitive impairment and an increased risk of AD, but the impact of treating OSA on AD biomarkers or dementia prevention remains unclear and requires further investigation.", "population_specificity": "Middle-aged and elderly populations, particularly those with OSA and cognitive impairment or AD.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:53.067846+00:00"}
{"study_id": 53032, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of hypoglossal nerve stimulation (HNS) and alternative surgical interventions for managing obstructive sleep apnea (OSA) in patients with CPAP intolerance.", "results_summary": "HNS showed significantly lower post-treatment apnea-hypopnea index (AHI) compared to other airway surgeries, but no significant differences in achieving AHI <5 events/h or postoperative ESS scores. HNS was deemed effective for selected patients with moderate-to-severe OSA and CPAP intolerance.", "population_specificity": "Patients with moderate-to-severe obstructive sleep apnea (OSA) and CPAP intolerance.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:53.082921+00:00"}
{"study_id": 53034, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of awake prone positioning (APP) in patients with COVID-19 receiving advanced respiratory support, including Continuous Positive Airway Pressure (CPAP).", "results_summary": "The panel strongly recommends APP over standard supine care for COVID-19 patients on advanced respiratory support (including CPAP), citing high-quality evidence. No recommendation was made for patients on conventional oxygen therapy or non-COVID-19 AHRF due to insufficient evidence.", "population_specificity": "Patients with acute hypoxaemic respiratory failure (AHRF) due to COVID-19 receiving advanced respiratory support (high-flow nasal cannula, CPAP, or non-invasive ventilation).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:54.025606+00:00"}
{"study_id": 53036, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to summarize the relationship between obstructive sleep apnea (OSA) and stroke, including the effects of OSA on stroke onset, recurrence, prognosis, and the potential benefits of CPAP treatment in poststroke patients with OSA.", "results_summary": "The study found that OSA promotes stroke onset and recurrence and may worsen poststroke prognosis. CPAP and other treatments may benefit poststroke patients with OSA, but long-term effects are not well documented.", "population_specificity": "Poststroke patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:57.466547+00:00"}
{"study_id": 53038, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the long-term effectiveness of multi-level upper airway surgery compared to ongoing medical management (including Continuous Positive Airway Pressure) in patients with moderate or severe OSA who failed CPAP therapy.", "results_summary": "The study found that multi-level surgery led to persistent improvements in AHI and ESS scores over a mean follow-up of 3.5 years, with stable outcomes and minor adverse events. Control participants who underwent subsequent surgery also reported symptom and quality-of-life improvements.", "population_specificity": "Adults with moderate or severe obstructive sleep apnea (OSA) who failed continuous positive airway pressure therapy.", "effective_dosage": "Not available", "study_duration": "Mean follow-up of 3.5 years post-surgery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:00.271368+00:00"}
{"study_id": 53037, "supplement_id": 1048, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of Continuous Positive Airway Pressure (CPAP) on cardiovascular outcomes in patients with sleep-disordered breathing (SDB) and established cardiovascular disease (CVD), particularly heart failure (HF) and atrial fibrillation (AF).", "results_summary": "CPAP use for over 4 hours daily reduced major adverse cardiovascular events in CVD patients with obstructive sleep apnoea (OSA) but did not reduce mortality. In AF patients with OSA, CPAP was associated with reduced AF recurrence post-ablation. In HF patients with OSA, CPAP improved symptoms and cardiac markers, but survival data were lacking. CPAP's role in central sleep apnoea (CSA) with HF remains unclear, with potential harm observed in some cases.", "population_specificity": "Patients with established cardiovascular disease (CVD), including heart failure (HF) and atrial fibrillation (AF), who also have sleep-disordered breathing (SDB), particularly obstructive sleep apnoea (OSA) or central sleep apnoea (CSA).", "effective_dosage": "Over 4 hours daily", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:01.208115+00:00"}
{"study_id": 53041, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the safety and efficacy of high flow nasal cannula (HFNC) oxygen therapy compared to other forms of non-invasive respiratory support, including Continuous Positive Airway Pressure (CPAP), in term infants.", "results_summary": "HFNC showed little to no difference in treatment failure compared to CPAP, with uncertain effects on the duration of respiratory support. HFNC likely resulted in little to no difference in ICU length of stay but may reduce nasal trauma and abdominal overdistension, though evidence is very uncertain.", "population_specificity": "Term infants (\u226537 weeks gestational age up to one month postnatal age).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:01.929988+00:00"}
{"study_id": 53039, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the 3-month efficacy of fixed CPAP versus auto-adjusted CPAP (APAP) in treating severe obstructive sleep apnoea (OSA).", "results_summary": "Both fixed CPAP and APAP showed similar efficacy, with no significant differences in residual apnoea hypopnoea index (AHI), Epworth Score, tolerance, adherence, quality of life, or blood pressure effects. Approximately 70% of patients in both groups achieved AHI <10/h and Epworth Score <11.", "population_specificity": "801 patients with severe OSA across 22 French centres.", "effective_dosage": "Not specified (pressure levels determined by APAP during initial 7-day period).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:02.085620+00:00"}
{"study_id": 53042, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether listening to music during CPAP reduces agitation levels and improves treatment compliance in COVID-19 intensive care patients.", "results_summary": "The study found that listening to music during CPAP significantly reduced agitation levels (measured by RASS scores) at 15 and 30 minutes compared to the control group, and improved compliance with the treatment.", "population_specificity": "Intensive care patients with COVID-19 requiring CPAP therapy.", "effective_dosage": "Not specified", "study_duration": "30 minutes", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:03.024753+00:00"}
{"study_id": 53040, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to describe adherence to positive airway pressure therapy in adults with neurodegenerative diseases and OSA, identify predictors of adherence, and assess its effects on cognitive function, quality of life, and caregiver satisfaction.", "results_summary": "Adherence rates varied widely (28-61% in MCI/AD, 15-25% upfront refusal in PD, 69-72% acceptance in MSA), with improvements in daytime sleepiness, depressive symptoms, sleep quality, and certain cognitive functions in adherent patients. However, attrition rates were high (12-75%), and predictors of adherence included age, race, disease duration, and motor symptoms.", "population_specificity": "Adults with neurodegenerative diseases (MCI, AD, PD, MSA) and obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Ranged from 6 weeks to 3.3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:04.802782+00:00"}
{"study_id": 53044, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effectiveness and safety of Nasal Intermittent Positive Pressure Ventilation (NIPPV) versus Nasal Continuous Positive Airway Pressure (NCPAP) in reducing respiratory failure and reintubation in preterm infants post-extubation.", "results_summary": "NIPPV likely reduces respiratory failure and reintubation rates compared to NCPAP, with potential benefits in reducing pulmonary air leaks, but shows no significant difference in gastrointestinal perforation, necrotising enterocolitis, chronic lung disease, or mortality. Ventilator-generated NIPPV appears superior to bilevel devices in reducing respiratory failure.", "population_specificity": "Preterm infants (less than 37 weeks' gestational age) ready for extubation to non-invasive respiratory support.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:07.128802+00:00"}
{"study_id": 53045, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of CPAP on preventing major cardiovascular events (MACEs) in patients with moderate-to-severe obstructive sleep apnea and coronary artery disease.", "results_summary": "CPAP therapy was associated with a modest reduction in MACEs (RR 0.87) and may prevent all-cause death. Benefits were greater with CPAP use exceeding 4 hours/night.", "population_specificity": "Patients with moderate-to-severe obstructive sleep apnea and coronary artery disease.", "effective_dosage": "CPAP use exceeding 4 hours/night.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:08.431695+00:00"}
{"study_id": 53046, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy and safety of non-invasive high-frequency oscillatory ventilation (nHFOV) versus nasal continuous positive airway pressure (nCPAP) in reducing the duration of non-invasive respiratory support for neonates with transient tachypnea of the newborn (TTN).", "results_summary": "The study found no significant difference in the median duration of non-invasive respiratory support between nHFOV and nCPAP initially, but after adjusting for confounders, nHFOV was associated with a shorter duration. nHFOV was well tolerated and did not increase complication risks.", "population_specificity": "Late preterm and term infants >34 weeks' gestation with TTN.", "effective_dosage": "Standard settings (specific dosage not detailed).", "study_duration": "Median duration was 21 hours for nHFOV and 15 hours for nCPAP.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:11.038176+00:00"}
{"study_id": 53048, "supplement_id": 1048, "safety_score": "75", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to assess the effects of CPAP on apnoea of prematurity (AoP) in preterm infants and compare different CPAP delivery systems.", "results_summary": "The study found insufficient evidence to determine whether any CPAP device is more effective than other forms of supportive care, other CPAP devices, or mechanical ventilation for AoP. Data were limited, with only single-study comparisons available for each device type.", "population_specificity": "Preterm infants (born before 37 weeks) with a mean/median gestation of 26 to 28 weeks.", "effective_dosage": "Pressures between 4 and 6 cm H\u2082O.", "study_duration": "6 to 48 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:11.531824+00:00"}
{"study_id": 53049, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess whether a tailored intervention program could improve CPAP use and self-efficacy in individuals with obstructive sleep apnea (OSA).", "results_summary": "CPAP use was significantly higher in the intervention group (PSY CPAP) compared to the control group (TAU CPAP) at all time points. Outcome expectancies improved significantly in the intervention group, and changes in risk perception were associated with CPAP use at 1 week.", "population_specificity": "81 participants (mean age 52.1 \u00b1 11.6 years; 35 females) with OSA.", "effective_dosage": "Not specified", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:11.558861+00:00"}
{"study_id": 53047, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine whether combining CPAP with a mandibular advancement device (MAD) could reduce CPAP pressure requirements and improve adherence in patients with moderate to severe obstructive sleep apnoea (OSA).", "results_summary": "The study proposes a randomized crossover trial to compare standalone CPAP with CPAP + MAD therapy, measuring adherence, OSA severity, and patient-reported outcomes. The abstract suggests potential benefits of combination therapy but does not yet report final results.", "population_specificity": "Consecutive patients with moderate to severe OSA starting CPAP therapy at a regional NHS sleep service.", "effective_dosage": "Not specified (auto-titrating CPAP machines used).", "study_duration": "12 weeks per treatment arm (including 2 weeks acclimatization).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:11.577024+00:00"}
{"study_id": 53050, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 54, "quality_score": 70, "study_goal": "The researchers aimed to assess the feasibility and outcomes of non-invasive respiratory supports, including CPAP, in internal medicine high-dependency wards for COVID-19 patients with acute respiratory failure.", "results_summary": "CPAP showed a success rate of 54% in weaning patients off respiratory support, with a 47% success rate in patients with a do-not-intubate status. Older age, chronic ischemic heart disease, high respiratory rate after 24 hours, and suspected ARDS were predictors of mortality or endotracheal intubation.", "population_specificity": "COVID-19 patients with acute respiratory failure admitted to internal medicine high-dependency wards, median age 74 years, including those with do-not-intubate status.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:14.797079+00:00"}
{"study_id": 53053, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether CPAP therapy influences BNP levels in patients with OSAHS and assess its accuracy as an index for evaluating heart function.", "results_summary": "The meta-analysis found that CPAP therapy did not significantly change BNP levels in OSAHS patients, suggesting BNP is not a reliable indicator of heart function in this context.", "population_specificity": "Patients with Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:15.732719+00:00"}
{"study_id": 53055, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify predictors of successful treatment with aerosolized surfactant in neonates receiving nasal continuous positive airway pressure (NCPAP).", "results_summary": "The study found that gestational age \u226531 weeks, respiratory severity score (RSS) <1.9, and fewer than two previous aerosol treatments were predictive of successful treatment, with 24% of infants requiring rescue intubation.", "population_specificity": "Neonates receiving NCPAP at the time of first aerosolized calfactant administration.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:19.045892+00:00"}
{"study_id": 53056, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the efficacy of combined noradrenergic and antimuscarinic agents as pharmacotherapy for obstructive sleep apnea (OSA), particularly in comparison to placebo.", "results_summary": "The study found a modest but significant reduction in apnea-hypopnea index (AHI) and improvement in lowest oxygen saturation with the combined regimen, particularly in male OSA patients. The effects were statistically significant but clinically modest.", "population_specificity": "OSA patients, with a noted stronger effect in male participants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:19.475843+00:00"}
{"study_id": 53057, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of maxillomandibular advancement (MMA) as a surgical treatment for obstructive sleep apnea (OSA) in patients intolerant to continuous positive airway pressure (CPAP).", "results_summary": "The study found that MMA has a surgical success rate of 86% and an OSA cure rate of 43.2%, demonstrating its potential as an effective treatment for OSA in CPAP-intolerant patients.", "population_specificity": "Patients with obstructive sleep apnea who have difficulty tolerating CPAP and whose OSA has been refractory to other surgical modalities.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:20.313381+00:00"}
{"study_id": 53054, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of NCPAP and HHHFNC on feeding intolerance and respiratory outcomes in high-risk preterm infants with respiratory distress syndrome.", "results_summary": "The study found no significant differences in feeding intolerance or nutritional outcomes between NCPAP and HHHFNC groups, but NCPAP showed better respiratory effectiveness (higher SpO2-FIO2 ratio and lower rate of ineffectiveness) compared to HHHFNC.", "population_specificity": "Preterm infants with a gestational age of 25 to 29 weeks, medically stable on noninvasive respiratory support for at least 48 hours.", "effective_dosage": "Not specified", "study_duration": "Intervention duration not explicitly stated, but outcomes were measured within the first week of life and included time to full enteral feeding (median 14 days).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:21.017521+00:00"}
{"study_id": 53059, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 65, "quality_score": 90, "study_goal": "The researchers aimed to determine if a nasal CPAP mask reduces hypoxemic events in obese and obstructive sleep apnea patients undergoing colonoscopy under propofol anesthesia.", "results_summary": "Nasal CPAP did not significantly reduce hypoxemia compared to a simple face mask but required fewer airway maneuvers. Patient tolerance was lower with nasal CPAP.", "population_specificity": "Obese and/or obstructive sleep apnea patients undergoing colonoscopy under propofol general anesthesia.", "effective_dosage": "Supplementary oxygen at 10 L/min.", "study_duration": "Duration of colonoscopy procedure.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:22.665535+00:00"}
{"study_id": 53058, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop an AI model to interpret neonatal lung ultrasound scores (LUS) for predicting the need for CPAP and surfactant therapy.", "results_summary": "The AI model showed good accuracy in predicting the need for CPAP (AUROC 0.88 at T0, 0.80 at T1) and surfactant therapy (AUROC 0.84 at T0, 0.89 at T1), with identified cutoffs for LUS and AI scores.", "population_specificity": "Newborns with gestational age \u226533 weeks presenting with early tachypnea, dyspnea, or oxygen requirements.", "effective_dosage": "Not specified", "study_duration": "LU scans were performed within 3h of life (T0), at 4-6h (T1), and after respiratory support cessation (T2).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:22.820031+00:00"}
{"study_id": 53060, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the performance of a new CPAP device (\"Bag-CPAP\") designed to minimize oxygen consumption and compare it with other CPAP devices.", "results_summary": "Bag-CPAP demonstrated the highest oxygen-saving properties in vitro but increased work of breathing (WOB). Clinically, it was well accepted and reduced dyspnea, suggesting utility in treating acute respiratory failure, especially under oxygen delivery constraints.", "population_specificity": "Patients with acute respiratory failure (specific details not provided).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:23.594221+00:00"}
{"study_id": 53062, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether long-term CPAP adherence reduces cardiovascular events and mortality, independent of initial blood pressure response.", "results_summary": "Long-term CPAP adherence (>4 h/night) was associated with reduced all-cause mortality but not cardiovascular events. Baseline blood pressure predicted outcomes, while initial BP response to CPAP did not.", "population_specificity": "241 patients from the AgirSASadom randomized controlled trial (2010-2012).", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 113 months (interquartile range [102; 124])", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:27.568930+00:00"}
{"study_id": 53061, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of close monitoring on compliance with positive airway pressure (PAP) treatment and identify factors influencing compliance among obstructive sleep apnea (OSA) patients.", "results_summary": "The study found no correlation between good CPAP compliance and diabetes, hypertension, hyperthyroidism, or allergic rhinitis, but identified a statistically significant correlation with COPD or asthma. Adherence to CPAP remains a global challenge, with telemedicine and interpersonal communication suggested as potential follow-up tools.", "population_specificity": "192 adults (\u226518 years) newly diagnosed with OSA who underwent PAP titration at a single sleep laboratory.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:27.919017+00:00"}
{"study_id": 53051, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the risks and benefits of early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants at risk of or with respiratory distress syndrome (RDS).", "results_summary": "NIPPV likely reduces respiratory failure and the need for intubation compared to NCPAP, and may slightly decrease chronic lung disease (CLD) incidence, though mortality rates showed little to no difference. The results are based on moderate-certainty evidence from 17 randomized controlled trials.", "population_specificity": "Preterm infants (< 37 weeks' gestational age) with or at risk of RDS, primarily those with a gestational age of 28\u201332 weeks.", "effective_dosage": "Not specified", "study_duration": "Intervention started within six hours after birth; duration not explicitly stated.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:28.763845+00:00"}
{"study_id": 53064, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to test the inter- and intra-rater reliability of the Silverman and Andersen index (SA index) among neonatologists and nurses when assessing preterm infants on respiratory support, including Continuous Positive Airway Pressure (CPAP), and examine its association with diaphragm activity (Edi signals).", "results_summary": "The study found poor inter-rater reliability but good intra-rater reliability for the SA index when assessing preterm infants on CPAP and other respiratory supports. A moderate positive correlation was observed between diaphragm activity (Edi peak) and SA index scores.", "population_specificity": "Preterm infants in three newborn intensive care units in Norway.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:30.299170+00:00"}
{"study_id": 53066, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 85, "study_goal": "The researchers sought to evaluate the comparative effectiveness of noninvasive respiratory strategies, including CPAP, in preventing postoperative pulmonary complications after cardiac surgery.", "results_summary": "The study found that CPAP showed no significant beneficial effect on the incidence of postoperative pulmonary complications compared to usual care, though there was a downward trend in risk. CPAP ranked third in effectiveness among the interventions studied.", "population_specificity": "Patients undergoing cardiac surgery in the immediate postoperative period.", "effective_dosage": "Not specified", "study_duration": "Immediate postoperative period (specific duration not mentioned)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:30.563343+00:00"}
{"study_id": 53063, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to determine whether NHFOV is more effective than NIPPV and NCPAP in reducing the duration of invasive mechanical ventilation in extremely preterm neonates or those with severe respiratory failure.", "results_summary": "NIPPV and NHFOV were associated with significantly fewer reintubations and shorter IMV duration compared to NCPAP, with no significant differences between NIPPV and NHFOV. NHFOV also showed reduced moderate-to-severe bronchopulmonary dysplasia and better postextubation gas exchange.", "population_specificity": "Extremely preterm neonates (\u226428 weeks' gestation) or those with severe respiratory failure (prolonged IMV or high CO2 levels).", "effective_dosage": "Not specified (airway pressure higher in NHFOV than in NIPPV and NCPAP).", "study_duration": "From first extubation until NICU discharge.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:30.589040+00:00"}
{"study_id": 53065, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to synthesize existing literature on factors influencing adherence to mandibular advancement devices (MADs) in treating obstructive sleep apnea (OSA), comparing it to CPAP adherence.", "results_summary": "The study identified several factors negatively impacting MAD adherence (e.g., personality aspects, side effects, poor first experiences) and positively influencing adherence (e.g., therapy effectiveness, custom-made devices, practitioner communication). CPAP adherence factors were noted as more extensively studied than MAD adherence.", "population_specificity": "Adults with obstructive sleep apnea (OSA) or snoring combined with OSA.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:31.292056+00:00"}
{"study_id": 53067, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the physiological effects, indications, and clinical outcomes of various noninvasive respiratory support modes, including Continuous Positive Airway Pressure, in neonatal medicine.", "results_summary": "The abstract summarizes evidence for noninvasive respiratory support modes, highlighting their potential to reduce lung injury but noting unresolved questions about indications and clinical outcomes. It emphasizes the need for enhanced clinician awareness of each mode's strengths and limitations.", "population_specificity": "Neonates (newborn infants) in neonatal intensive care units.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:32.294412+00:00"}
{"study_id": 53068, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to review the mechanistic insights into how obstructive sleep apnoea (OSA) contributes to atrial fibrillation (AF) and assess the role of Continuous Positive Airway Pressure (CPAP) in mitigating AF burden in OSA patients.", "results_summary": "CPAP is effective in some groups for preventing AF in OSA patients but is limited by poor compliance. The study highlights the multifactorial arrhythmogenic mechanisms in OSA, including chronic intermittent hypoxia and atrial stretch, which contribute to AF.", "population_specificity": "Patients with obstructive sleep apnoea (OSA) and atrial fibrillation (AF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:36.361357+00:00"}
{"study_id": 53069, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of CPAP in modulating blood pressure and reducing preeclampsia in high-risk pregnant women with obstructive sleep apnea.", "results_summary": "CPAP treatment significantly lowered diastolic blood pressure and reduced the incidence of preeclampsia compared to usual antenatal care, with sustained blood pressure reductions throughout pregnancy.", "population_specificity": "Singleton pregnant women aged over 18 with high-risk conditions (e.g., chronic hypertension, obesity, history of preeclampsia or gestational diabetes) and mild-to-moderate OSA.", "effective_dosage": "Average use of 2.5 hours/night (adherence rate 32.7%).", "study_duration": "Throughout pregnancy, from first trimester (GA 0-16 weeks) to third trimester (GA 32-34 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:37.623853+00:00"}
{"study_id": 53071, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the role of oral appliance therapy (OAT) as an alternative to continuous positive airway pressure (CPAP) in managing obstructive sleep apnoea (OSA).", "results_summary": "The abstract highlights CPAP as the \"gold standard\" for nonsurgical OSA management, while OAT is recognized as an alternative. It discusses current clinical guidelines and the anatomical and physiological impacts of OAT.", "population_specificity": "Adults with obstructive sleep apnoea (OSA).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:38.150243+00:00"}
{"study_id": 53070, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the surgical outcome and risk of postoperative PICU intervention following supraglottoplasty (SGP) for severe laryngomalacia in children with high-risk comorbidities, including the use of assisted ventilation like Continuous Positive Airway Pressure (CPAP).", "results_summary": "The study found that SGP had an overall surgical success rate of 89.7%, with higher success in non-comorbid patients (94.7%) compared to high-risk comorbid patients (80.5%). Postoperative PICU intervention was not significantly increased in high-risk comorbid patients, and revision SGP, though more common in this group, had good outcomes.", "population_specificity": "Children with severe laryngomalacia, including those with high-risk comorbidities, treated at a tertiary pediatric airway surgery center.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:38.715486+00:00"}
{"study_id": 53075, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of CPAP therapy in improving clinical outcomes (COPD exacerbation, hospitalization, and mortality) in patients with COPD-OSA overlap syndrome.", "results_summary": "CPAP therapy improved clinical outcomes, including COPD exacerbation, hospitalization, and mortality in patients with COPD-OSA overlap syndrome, though definitions of COPD, OSA, and CPAP usage varied across studies.", "population_specificity": "Patients with COPD-OSA overlap syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:38.886508+00:00"}
{"study_id": 53072, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of synchronized nasal intermittent positive pressure ventilation (sNIPPV) and nasal high-frequency oscillatory ventilation (nHFOV) in reducing partial pressure of carbon dioxide (pCO2) after neonatal extubation.", "results_summary": "The study found that sNIPPV was associated with a lower pCO2 level compared to nHFOV after neonatal extubation, with no differences observed between preterm and very preterm neonates.", "population_specificity": "Preterm and very preterm neonates (mean gestational age ~32.8-33.5 weeks, median birth weight ~1,850-1,930 g).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:39.553249+00:00"}
{"study_id": 53076, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to compare the effect of telemonitoring versus standard clinic visits on CPAP adherence after 6 months and assess factors like side effects influencing adherence.", "results_summary": "Telemonitoring did not improve CPAP adherence compared to standard care. Side effects like dry throat, increased awakenings, exhaling problems, and smoking negatively impacted adherence.", "population_specificity": "217 patients prescribed CPAP for obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:39.640019+00:00"}
{"study_id": 53074, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to assess the impact of sleep disturbances on functional outcomes post-stroke and evaluate the benefit of Continuous Positive Airway Pressure (CPAP) in patients with severe obstructive sleep apnea (OSA).", "results_summary": "The study found no significant differences in functional outcomes (Barthel Index, modified Rankin score, Stroke Scale) between CPAP-treated and sham-CPAP groups at 3 months post-stroke. Poorer outcomes were associated with lower nocturnal oxygen saturation, insomnia, restless legs syndrome, depressive symptoms, and reduced sleep time, but not with apnea-hypopnea index severity.", "population_specificity": "61 patients (71.8 years, 42.6% men) with supra-tentorial ischaemic stroke and severe obstructive sleep apnea (AHI \u2265 30/hr).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:40.951496+00:00"}
{"study_id": 53080, "supplement_id": 1048, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to investigate the associations between self-reported oral moistening disorders (OMDs) and OSA, as well as the effects of CPAP and MAD treatments on OMDs and treatment adherence.", "results_summary": "The study found that xerostomia is a common side effect of CPAP, though some studies noted it diminishes with therapy. CPAP was not strongly associated with drooling, and OMDs generally did not significantly impact treatment adherence.", "population_specificity": "Patients with obstructive sleep apnoea (OSA).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:46.074688+00:00"}
{"study_id": 53079, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of emergency care interventions, including Continuous Positive Airway Pressure (CPAP), on clinical outcomes for pediatric patients with severe acute respiratory infections (SARIs) in low- and middle-income countries.", "results_summary": "The study found inconclusive results on the utility of CPAP for improving clinical outcomes in pediatric SARI cases, though respiratory support interventions overall showed the strongest evidence for benefit in reducing mortality. Further research on CPAP in diverse settings was recommended.", "population_specificity": "Children aged 29 days to 19 years with severe acute respiratory infections (SARIs) in low- and middle-income countries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:46.713007+00:00"}
{"study_id": 53078, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to compare the effectiveness of high-flow nasal cannula (HFNC), helmet CPAP, and face-mask CPAP in reducing endotracheal intubation rates and mortality in COVID-19 patients with hypoxemic respiratory failure.", "results_summary": "The study found no significant differences in intubation rates or mortality among HFNC, helmet CPAP, and face-mask CPAP groups at 28 and 90 days. The trial was stopped prematurely due to declining cases, limiting definitive conclusions.", "population_specificity": "Adult COVID-19 patients with a PaO2/FiO2 ratio <300 admitted to tertiary centers in Oman.", "effective_dosage": "Not specified", "study_duration": "Median intubation times ranged from 4.5 to 7.0 days across groups.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:47.486009+00:00"}
{"study_id": 53082, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy of CPAP, HFNC, and BiPAP against conventional oxygen therapy in preventing extubation failure and treatment failure in critically ill children.", "results_summary": "CPAP was found to be more effective than conventional oxygen therapy in reducing extubation failure and treatment failure, with the highest likelihood of being the best intervention. However, CPAP and BiPAP showed modest increases in nasal injury and abdominal distension compared to COT.", "population_specificity": "Critically ill children receiving invasive mechanical ventilation for more than 24 hours.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:47.541058+00:00"}
{"study_id": 53081, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare the impact of high-flow nasal cannula (HFNC) oxygen therapy versus nasal continuous positive airway pressure (nCPAP) or usual care on early prognosis in patients with sleep apnea after acute ischemic stroke (AIS).", "results_summary": "The study protocol describes a randomized controlled trial comparing HFNC, nCPAP, and standard oxygen therapy in AIS patients with sleep apnea, focusing on 28-day mortality, pulmonary infection, and endotracheal intubation rates. Results are pending as the study is ongoing.", "population_specificity": "Patients with sleep apnea following acute ischemic stroke (AIS) in an intensive care unit setting.", "effective_dosage": "Not specified", "study_duration": "Follow-up occurs three months post-discharge, but intervention duration is not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:48.173158+00:00"}
{"study_id": 53084, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate how incremental CPAP pressure levels affect upper airway dimensions and inspiratory flow, particularly focusing on the epiglottis in OSA patients.", "results_summary": "CPAP increased cross-sectional dimensions of the soft palate, lateral walls, and tongue base but not the epiglottis, and induced epiglottis collapse in one subject. Despite persistent epiglottis collapse, CPAP improved peak inspiratory flow and median ventilation in all patients.", "population_specificity": "13 participants with moderate to severe OSA (median AHI 24.9 events/h, BMI 28.1 kg/m\u00b2).", "effective_dosage": "Incremental CPAP titration (specific pressures not detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:49.401991+00:00"}
{"study_id": 53083, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of continuous positive airway pressure (CPAP) as a non-invasive respiratory support modality for patients with acute dyspnea, particularly in cases associated with respiratory failure.", "results_summary": "The study highlights CPAP as an effective and practical non-invasive option for managing dyspnea requiring ventilatory support, avoiding the need for invasive mechanical ventilation. It emphasizes its utility alongside other diagnostic tools like lung ultrasound and echocardiography.", "population_specificity": "Patients with acute dyspnea, particularly those with respiratory failure or requiring ventilatory support.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:49.426160+00:00"}
{"study_id": 53085, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of respiratory muscle training (including inspiratory and expiratory muscle training) in treating patients with obstructive sleep apnea.", "results_summary": "Inspiratory muscle training showed probable improvements in systolic blood pressure and sleepiness but had mixed or no significant effects on other outcomes like diastolic blood pressure, apnea-hypopnea index, and quality of life. Expiratory muscle training may improve expiratory muscle strength and sleep quality but had uncertain effects on the apnea-hypopnea index.", "population_specificity": "Patients with obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:49.426969+00:00"}
{"study_id": 53087, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop and validate a nomogram for predicting extubation failure in preterm infants receiving different modes of noninvasive ventilation, including Continuous Positive Airway Pressure.", "results_summary": "The study found that Continuous Positive Airway Pressure was associated with a higher risk of extubation failure compared to other noninvasive ventilation modes. The nomogram demonstrated good predictive accuracy and clinical utility in both training and validation cohorts.", "population_specificity": "Preterm infants with gestational age between 25 and 29 weeks.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:54.929473+00:00"}
{"study_id": 53086, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of mandibular advancement devices (MAD) versus continuous positive airway pressure (CPAP) in reducing blood pressure and improving health-related outcomes in patients with moderate-to-severe obstructive sleep apnea (OSA).", "results_summary": "The study is a randomized controlled trial designed to evaluate whether MAD is non-inferior to CPAP in improving blood pressure and other health outcomes in OSA patients, but specific results are not yet available as the study is ongoing.", "population_specificity": "220 Asians with hypertension and high cardiovascular risk, diagnosed with moderate-to-severe OSA (apnea-hypopnea index \u226515 events/hour).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:55.226993+00:00"}
{"study_id": 53088, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the safety of danavorexton and its effects on residual excessive daytime sleepiness in patients with obstructive sleep apnea despite adequate CPAP use.", "results_summary": "Danavorexton improved subjective and objective measures of excessive daytime sleepiness compared to placebo, with mild to moderate treatment-related adverse events but no serious safety concerns.", "population_specificity": "Adults aged 18-67 with obstructive sleep apnea and adequate CPAP use.", "effective_dosage": "Single IV infusions of danavorexton 44 mg and 112 mg.", "study_duration": "Single-dose intervention (duration not specified beyond this).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:55.472705+00:00"}
{"study_id": 53090, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore whether distinct endotypes and phenotypes of OSA exist and whether personalized therapy, including Continuous Positive Airway Pressure, could be more effective than traditional approaches.", "results_summary": "The abstract highlights recent advances in understanding OSA causes and subgroups, suggesting a shift toward personalized therapy, but does not provide specific efficacy data on Continuous Positive Airway Pressure.", "population_specificity": "Patients with obstructive sleep apnoea (OSA), particularly those with increased risk of cardiovascular complications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:56.168606+00:00"}
{"study_id": 53089, "supplement_id": 1048, "safety_score": "60", "efficacy_score": 75, "quality_score": 80, "study_goal": "To issue practical recommendations for optimal nasal skin care when non-invasive ventilation support is used in preterm infants.", "results_summary": "Nasal injuries were frequent in preterm infants, especially those born under 30 weeks of gestational age or below 1500 g. Effective prevention strategies included hydrocolloid use, mask preference, and interface rotation.", "population_specificity": "Preterm newborn infants, particularly those born under 30 weeks of gestational age or below 1500 g.", "effective_dosage": "Not specified", "study_duration": "Lesions appeared early (2-3 days for cutaneous, 8-9 days for intranasal).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:56.698665+00:00"}
{"study_id": 53091, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the effect of digitally generated personalized education and feedback on CPAP adherence and whether tailoring the style to psychological profiles further improved adherence.", "results_summary": "Personalized education and feedback significantly increased CPAP adherence (81.3 more minutes per night and 0.9 more nights per week), but tailoring the style to psychological profiles did not provide additional benefits.", "population_specificity": "169 participants recruited from 6 US sleep clinics with obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:57.223987+00:00"}
{"study_id": 53092, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "To evaluate the effectiveness of supplemental oxygen therapy and high-flow nasal cannula (HFNC) therapy in patients with obstructive sleep apnea (OSA), particularly in postoperative settings.", "results_summary": "Oxygen therapy significantly reduced the apnea-hypopnea index (AHI) by 31% and increased oxyhemoglobin saturation (SpO\u2082). HFNC therapy also showed effectiveness in improving oxygenation.", "population_specificity": "1395 OSA patients for oxygen therapy and 228 OSA patients for HFNC therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:57.498370+00:00"}
{"study_id": 53093, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the antihypertensive effect of CPAP in patients with severe obstructive sleep apnea (OSA) and untreated hypertension, focusing on BP surge profiles as predictors of response.", "results_summary": "CPAP led to modest BP reductions overall, with significantly greater decreases in patients with high BP surge profiles, particularly in asleep systolic BP. Long-term follow-up in the high BP surge group showed optimal BP control in 60% of patients and BP <140/90 mmHg in 83.3% after 24 months.", "population_specificity": "130 subjects with severe OSA and untreated hypertension.", "effective_dosage": "Not specified", "study_duration": "4 weeks (initial evaluation), with a subset followed for 24 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:58.977581+00:00"}
{"study_id": 53094, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to assess the effect of Continuous Positive Airway Pressure (CPAP) on left ventricular diastolic function in patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found that CPAP therapy significantly increased the left ventricular E/A ratio in OSA patients, suggesting improved diastolic function. However, the small number of included studies (n=7) limits confidence in the findings.", "population_specificity": "Adults (\u226518 years) diagnosed with OSA via polysomnography, excluding those with central sleep apnea or organic heart diseases.", "effective_dosage": "Not specified", "study_duration": "\u22654 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:03.512104+00:00"}
{"study_id": 53097, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the impact of predisposing conditions, including continuous positive airway pressure (CPAP), on outcomes of tension pneumocranium following transnasal transsphenoidal surgeries.", "results_summary": "The study did not find conclusive evidence linking CPAP to specific outcomes in tension pneumocranium, nor did it influence the incidence of meningitis or mortality.", "population_specificity": "Patients who underwent endoscopic transnasal transsphenoidal surgeries, particularly those with nonfunctional pituitary adenomas.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:04.337218+00:00"}
{"study_id": 53095, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy of heated high-flow nasal cannula (HFNC) therapy with continuous positive airway pressure (CPAP) in treating moderate-to-severe obstructive sleep apnea (OSA) in children with obesity and medical complexity.", "results_summary": "The study found that HFNC and CPAP therapy yielded similar reductions in OSA severity measures, including obstructive apnea/hypopnea index (OAHI), nadir oxygen saturation, oxygen desaturation index, and sleep efficiency, with no statistically significant differences between the two treatments.", "population_specificity": "Children aged 2-18 years with obesity and medical complexity diagnosed with moderate-to-severe OSA.", "effective_dosage": "Not specified", "study_duration": "Not specified (two sleep studies per participant, order randomized)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:04.844843+00:00"}
{"study_id": 53096, "supplement_id": 1048, "safety_score": "75", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the benefits and harms of nasal high flow (nHF) therapy compared to other forms of non-invasive respiratory support, such as Continuous Positive Airway Pressure (CPAP), for primary respiratory support in preterm infants.", "results_summary": "Compared to CPAP, nHF may result in little to no difference in death or bronchopulmonary dysplasia (BPD) but likely increases treatment failure within 72 hours. However, nHF likely reduces nasal trauma and pneumothorax rates.", "population_specificity": "Preterm infants born less than 37 weeks' gestation with respiratory distress soon after birth.", "effective_dosage": "Gas flows of 2 L/min to 8 L/min.", "study_duration": "Outcomes assessed within 72 hours of trial entry and up to hospital discharge.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:05.102923+00:00"}
{"study_id": 53098, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether patients with obstructive sleep apnoea (OSA) undergoing bariatric surgery face increased risks of complications, ICU admission, and longer hospital stays compared to non-OSA patients.", "results_summary": "The study found that OSA patients had a higher risk of cardiac complications post-bariatric surgery but no significant differences in respiratory complications, length of stay, 30-day readmission, or ICU admission compared to non-OSA patients.", "population_specificity": "Patients undergoing bariatric surgery, with and without obstructive sleep apnoea (OSA).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:05.389978+00:00"}
{"study_id": 53101, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the association between circulating galectin-3 levels and obstructive sleep apnea (OSA), including the effects of CPAP therapy on galectin-3 levels.", "results_summary": "The study found that CPAP therapy significantly reduced galectin-3 levels in patients with OSA, suggesting its potential utility as a biomarker for OSA severity and treatment response.", "population_specificity": "987 cases with OSA, mean age of 54.4 years.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:06.904072+00:00"}
{"study_id": 53099, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine the prevalence of CPAP failure among premature newborns with RDS and identify associated factors in a low-resource setting.", "results_summary": "CPAP failure occurred in 37.4% of preterm neonates with RDS, with higher rates (44.1%) in those weighing \u22641200g. Mortality was significantly higher among those who failed CPAP (33.8%) compared to those who did not (12.8%). No independent factors were identified for CPAP failure.", "population_specificity": "Preterm newborns (24-34 weeks gestation, 800-1500g) with respiratory distress syndrome (RDS) at Muhimbili National Hospital.", "effective_dosage": "CPAP with PEEP of 6 cmH2O and 50% oxygen.", "study_duration": "First 72 hours of life.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:07.509431+00:00"}
{"study_id": 53100, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers compared the need for respiratory support, including Continuous Positive Airway Pressure (CPAP), in infants with SARS-CoV-2-related bronchiolitis versus those with bronchiolitis caused by other viruses.", "results_summary": "Infants with SARS-CoV-2-related bronchiolitis required CPAP less frequently (1.0%) compared to those with other viral bronchiolitis (6.6%), suggesting a milder clinical course for SARS-CoV-2 cases. The study did not evaluate CPAP's efficacy directly but noted its reduced use in SARS-CoV-2-positive infants.", "population_specificity": "Infants diagnosed with bronchiolitis in 22 pediatric emergency departments across Europe and Israel.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:08.514862+00:00"}
{"study_id": 53102, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential benefits of OSA treatment, including Continuous Positive Airway Pressure, on AF-related outcomes and the relationship between OSA and AF.", "results_summary": "The abstract highlights observational studies suggesting potential benefits of OSA treatment in AF-related outcomes but does not provide specific results on Continuous Positive Airway Pressure's effects. It emphasizes the need for future studies to address outstanding questions.", "population_specificity": "Patients with atrial fibrillation (AF) and obstructive sleep apnea (OSA).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:11.574839+00:00"}
{"study_id": 53104, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess whether CPAP and MADs reduce depression symptoms in patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found that CPAP improved depressed mood in OSA patients compared to controls, with small heterogeneity among trials. MADs showed no significant effect on depressive symptoms.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:11.983891+00:00"}
{"study_id": 53105, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the use of nasal CPAP in preterm infants with respiratory distress syndrome and compare different CPAP systems for clinical benefits.", "results_summary": "The abstract highlights controversies in CPAP use due to non-uniform devices, study design differences, and short study periods. It suggests variable fluidic flow-opposition CPAP systems may offer advantages over constant-pressure systems, but more randomized trials are needed for clarity.", "population_specificity": "Preterm infants with respiratory distress syndrome at birth or after extubation from mechanical ventilation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:13.129395+00:00"}
{"study_id": 53103, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of postoperative prophylactic CPAP on preventing pneumonia in patients after open visceral surgery.", "results_summary": "The study found that postoperative intermittent CPAP significantly reduced the rate of pneumonia (5.6% vs. 25.9% in the control group) and was associated with shorter hospital stays, particularly in high-risk patients.", "population_specificity": "Patients who underwent open major visceral surgery (mean age 68.62 years, 56.6% male).", "effective_dosage": "15-minute CPAP sessions, 3-5 times daily.", "study_duration": "Not specified (intervention occurred during postoperative recovery).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:13.265467+00:00"}
{"study_id": 53106, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify factors affecting CPAP therapy adherence during diagnostic and titration polysomnography and assess its impact on sleep parameters.", "results_summary": "The study found that 67.4% of patients showed good CPAP adherence, which correlated with significant improvements in sleep parameters like apnea-hypopnea index, sleep efficacy, and self-reported sleep quality. Polysomnographic evaluations and self-reported sleep improvement could predict CPAP adherence.", "population_specificity": "463 patients with obstructive sleep apnea who underwent diagnostic and titration polysomnography.", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:13.864921+00:00"}
{"study_id": 53107, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the challenges of CPAP adherence in OSA patients, explore factors contributing to non-adherence, and evaluate strategies to improve adherence.", "results_summary": "CPAP is highly effective for improving symptoms and quality of life in OSA patients, but adherence remains a major issue, with up to 50% discontinuing use within 3 years. Strategies like telehealth, behavioral interventions, and improved remote monitoring platforms may enhance adherence.", "population_specificity": "Patients with obstructive sleep apnea (OSA)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:15.097231+00:00"}
{"study_id": 53108, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether CPAP could improve glucose or lipid metabolism in OSA patients compared to other control treatments.", "results_summary": "CPAP modestly improved insulin sensitivity and total cholesterol levels, with greater effects in pre-diabetic/type 2 diabetic patients and those with sleepy OSA. However, it did not significantly affect glycated hemoglobin, triglycerides, HDL-, or LDL-cholesterol.", "population_specificity": "Patients with obstructive sleep apnea (OSA), including subgroups like pre-diabetic/type 2 diabetic patients and those with severe OSA and oxygen desaturations.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:15.844266+00:00"}
{"study_id": 53110, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to highlight recent advances in respiratory support, including the role of Continuous Positive Airway Pressure (CPAP) in reducing the need for invasive ventilation and improving patient outcomes.", "results_summary": "The abstract notes that the success of CPAP and other non-invasive modes depends largely on choosing and maintaining a suitable interface, but does not provide specific efficacy data. Advances in respiratory support focus on minimizing lung injury and improving patient comfort.", "population_specificity": "Sick children, particularly those requiring respiratory support.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:19.307157+00:00"}
{"study_id": 53111, "supplement_id": 1048, "safety_score": "65", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the effectiveness and safety of bubble CPAP versus other pressure sources (mechanical ventilators or Infant Flow Driver) in reducing treatment failure and associated morbidity and mortality in preterm infants with or at risk of respiratory distress.", "results_summary": "Bubble CPAP may reduce treatment failure rates compared to other pressure sources but likely increases the risk of moderate-severe nasal injury. No significant differences were found in mortality, pneumothorax, or bronchopulmonary dysplasia between pressure sources.", "population_specificity": "Preterm infants with or at risk of respiratory distress.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:20.251201+00:00"}
{"study_id": 53112, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of CPAP therapy on myocardial performance in patients with severe obstructive sleep apnea (OSA).", "results_summary": "The study compared CPAP therapy to sham treatment in severe OSA patients over 3 months, assessing OSA severity metrics (AHI, ODI, T90, and average O2 levels), but specific outcomes on myocardial performance were not detailed in the abstract.", "population_specificity": "52 patients (mean age 49 years; 92% male; mean AHI 59) with severe OSA.", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:21.532274+00:00"}
{"study_id": 53113, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if Proportional Assist Ventilation with load-adjustable gain factors (PAV+) results in a shorter time to successful extubation compared to Pressure Support Ventilation (PSV) in patients with acute respiratory failure.", "results_summary": "The study suggests PAV+ may improve patient-ventilator synchrony and response to ventilatory demand compared to PSV, potentially benefiting difficult-to-wean patients, but definitive results on time to liberation were not provided in the abstract. Meta-analyses cited indicate PAV+ may reduce healthcare costs and improve outcomes.", "population_specificity": "Patients with acute respiratory failure who failed weaning criteria or spontaneous breathing trials.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:22.485116+00:00"}
{"study_id": 53116, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of various noninvasive respiratory support modes, including NCPAP, in preterm infants after extubation.", "results_summary": "The study found that NCPAP has known efficacy and safety in newborn infants needing respiratory support, while newer modes like HFNC are still under investigation. Long-term outcomes for preterm infants receiving noninvasive respiratory support remain unstudied.", "population_specificity": "Preterm infants with respiratory distress after extubation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:23.477448+00:00"}
{"study_id": 53114, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the severity of COVID-19, including CPAP/NIV use, between patients infected in winter versus spring/summer.", "results_summary": "CPAP/NIV use was significantly lower in spring/summer (14.1%) compared to winter (23.8%), suggesting reduced disease severity in warmer months. Multivariate analysis confirmed a lower risk of CPAP/NIV use in spring/summer (adjusted OR 0.48).", "population_specificity": "8,221 COVID-19 patients (653 hospitalized) in Grosseto province, Italy, from December 2020 to July 2021.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:23.940891+00:00"}
{"study_id": 53115, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether rotating nasal mask and nasal prongs every 8 hours reduces nasal injury in preterm infants receiving nCPAP compared to continuous use of either interface alone.", "results_summary": "Rotation of nasal mask and prongs significantly reduced nasal injury compared to continuous prongs alone, with a trend toward reduced injury compared to continuous mask use, without affecting nCPAP failure rates or other neonatal outcomes.", "population_specificity": "Preterm infants under 35 weeks receiving nCPAP.", "effective_dosage": "Alternate rotation of nasal mask and prongs every 8 hours.", "study_duration": "Duration of nCPAP therapy (specific length not stated).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:23.956185+00:00"}
{"study_id": 53109, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of noninvasive respiratory support, including Continuous Positive Airway Pressure, on preventing and treating post-extubation respiratory failure in ICU patients.", "results_summary": "NRS, including CPAP, reduced re-intubations and ventilator-associated pneumonia compared to conventional oxygen therapy. Prophylactic NRS did not prevent extubation failure in low-risk or hypoxaemic patients but may reduce post-extubation respiratory failure in ICU patients overall.", "population_specificity": "ICU adult patients post-extubation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:26.821472+00:00"}
{"study_id": 53118, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether CPAP therapy reduces TNF-\u03b1 levels in patients with obstructive sleep apnea-hypopnea syndrome (OSAHS).", "results_summary": "The meta-analysis found that CPAP therapy significantly lowered TNF-\u03b1 levels in OSAHS patients, with consistent results across studies despite significant heterogeneity. Subgroup analyses suggested that geographic region (Asia) and publication year (2019) may contribute to the observed heterogeneity.", "population_specificity": "Patients with obstructive sleep apnea-hypopnea syndrome (OSAHS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:28.524345+00:00"}
{"study_id": 53117, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore the long-term cardiometabolic benefits of combining Continuous Positive Airway Pressure (CPAP) with a weight-loss Mediterranean diet/lifestyle intervention in patients with obstructive sleep apnea (OSA).", "results_summary": "The study found that combining CPAP with a Mediterranean diet/lifestyle intervention led to sustained improvements in cardiometabolic parameters, including lower insulin, triglycerides, and blood pressure, as well as reduced risk of metabolic syndrome, compared to standard care with CPAP alone. The Mediterranean lifestyle group showed the most significant benefits.", "population_specificity": "Adults with overweight/obesity and polysomnography-diagnosed moderate-to-severe OSA.", "effective_dosage": "Not specified (CPAP prescription details not provided).", "study_duration": "6-month intervention with follow-up at 12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:29.506373+00:00"}
{"study_id": 53119, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Continuous Positive Airway Pressure (CPAP) therapy improves estimated glomerular filtration rate (eGFR) in patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found no significant change in eGFR levels before and after CPAP usage overall. However, subgroup analysis revealed a decrease in eGFR after CPAP therapy in patients with OSA who used CPAP for more than 6 months and in elderly patients (>60 years).", "population_specificity": "Patients with obstructive sleep apnea (OSA), particularly those with chronic kidney disease.", "effective_dosage": "Not specified", "study_duration": "Varied, with subgroup analysis focusing on durations >6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:30.325830+00:00"}
{"study_id": 53122, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the relationship between obstructive sleep apnoea (OSA) and cardiovascular disease (CVD) and assess the effectiveness of continuous positive airway pressure (CPAP) in improving cardiovascular outcomes.", "results_summary": "Observational studies link OSA to adverse cardiovascular outcomes, but clinical trials show inconsistent evidence that CPAP improves these outcomes, possibly due to trial design limitations and low adherence. Emerging biomarkers may help identify OSA subtypes and predict treatment response.", "population_specificity": "Patients with cardiovascular disease and obstructive sleep apnoea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:30.991244+00:00"}
{"study_id": 53125, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effects of Yakson touch and mother's voice on pain and comfort levels of preterm infants during nasal CPAP application.", "results_summary": "The study found that Yakson touch was the most effective intervention for reducing pain and improving comfort during and after nasal CPAP application, followed by the combination of mother's voice and Yakson touch, and then mother's voice alone.", "population_specificity": "124 premature infants (28-37 weeks of age) receiving nasal CPAP in a NICU in southeastern Turkey.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:32.302833+00:00"}
{"study_id": 53123, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether mechanically-induced DIBH (MANIV-DIBH) using CPAP could improve positional breast stability, reproducibility, and OARs sparing compared to voluntary DIBH guided by SGRT.", "results_summary": "MANIV-DIBH demonstrated sub-millimetric non-inferiority in positional breast reproducibility and stability compared to sDIBH, while significantly reducing dose to critical OARs like the left anterior descending artery. Mechanical ventilation achieved comparable target irradiation accuracy with better OARs protection and repositioning.", "population_specificity": "66 patients eligible for adjuvant left whole-breast radiotherapy in supine position.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:32.830108+00:00"}
{"study_id": 53124, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the effects of Continuous Positive Airway Pressure (CPAP) therapy on normalizing EEG patterns in patients with obstructive sleep apnea (OSA).", "results_summary": "The study found that OSA patients exhibit distinctive EEG patterns, including increased slow activity during sleep and wakefulness, which are reversible with CPAP treatment. CPAP therapy effectively normalizes these EEG changes, though alternative treatments' effects on EEG were not studied.", "population_specificity": "Subjects with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:33.356246+00:00"}
{"study_id": 53126, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the technical aspects, clinical indications, advantages, and challenges of helmet CPAP for non-invasive ventilation in acute respiratory failure.", "results_summary": "Helmet CPAP was found to improve oxygenation, reduce intubation rates, and decrease mortality compared to conventional oxygen therapy, with additional benefits in tolerability, airway stability, and reduced aerosolization risk during infectious diseases like Covid-19.", "population_specificity": "Patients with acute respiratory failure, including those with acute cardiogenic pulmonary edema, Covid-19 pneumonia, immunocompromised status, acute chest trauma, and palliative care needs.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:35.392626+00:00"}
{"study_id": 53127, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether treating pregnant women with OSA using CPAP improves maternal or fetal outcomes compared to no or delayed treatment.", "results_summary": "CPAP use in pregnancy was well-tolerated with reasonable adherence and may reduce blood pressure, pre-eclampsia, and preterm birth while increasing neonatal birthweight. However, more rigorous trials are needed for definitive conclusions.", "population_specificity": "Pregnant women with obstructive sleep apnoea (OSA), particularly those living with obesity.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:36.247300+00:00"}
{"study_id": 53128, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to update evidence-based guidelines for managing Respiratory Distress Syndrome (RDS), including the role of non-invasive respiratory support like Continuous Positive Airway Pressure (CPAP).", "results_summary": "The guidelines recommend initiating non-invasive respiratory support (e.g., CPAP) from birth to improve outcomes, reduce chronic lung disease, and minimize mechanical ventilation. Early surfactant administration and caffeine therapy further enhance efficacy.", "population_specificity": "Preterm infants with or at risk of Respiratory Distress Syndrome (RDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:37.994495+00:00"}
{"study_id": 53130, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the impact of CPAP therapy on heart remodeling and diastolic dysfunction in patients with metabolic syndrome and moderate-to-severe obstructive sleep apnea.", "results_summary": "The study found that 6 months of CPAP therapy prevented atrial remodeling and increased the likelihood of reversing diastolic dysfunction in patients with metabolic syndrome and OSA.", "population_specificity": "Patients with a recent diagnosis of metabolic syndrome and moderate-to-severe obstructive sleep apnea (79% men, mean age 48 years, mean BMI 33 kg/m\u00b2).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:39.279330+00:00"}
{"study_id": 53132, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The study aimed to assess the safety and feasibility of in-hospital sacubitril/valsartan initiation in patients with acute decompensated heart failure and reduced ejection fraction, not specifically evaluating Continuous Positive Airway Pressure.", "results_summary": "The abstract does not report specific outcomes related to Continuous Positive Airway Pressure, only noting its use in 42% of patients during hospitalization.", "population_specificity": "Patients admitted for acute decompensated heart failure with reduced ejection fraction (median EF 25%) in two Italian centers.", "effective_dosage": "Not specified for Continuous Positive Airway Pressure.", "study_duration": "Not specified for Continuous Positive Airway Pressure.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:41.082249+00:00"}
{"study_id": 53133, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to assess the incidence and characteristics of hospital-acquired skin lesions, particularly those related to nasal continuous positive airway pressure (CPAP), in neonates over a 6-year period.", "results_summary": "The study found an increasing incidence of CPAP-related skin lesions, primarily affecting the nose root, though severity decreased over time. Device-related injuries, especially from nasal CPAP, were the most common type of pressure injury observed.", "population_specificity": "Neonates admitted to a Neonatal Intensive Care Unit (NICU) in a university-tertiary care center.", "effective_dosage": "Not specified", "study_duration": "Retrospective study spanning 6 years (2015-2020).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:41.626932+00:00"}
{"study_id": 53134, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To assess the efficacy and safety of high-flow nasal cannula (HFNC) in elderly patients with acute respiratory failure (ARF) not due to COVID-19, refractory to conventional oxygen therapy and/or intolerant to NIV or CPAP.", "results_summary": "HFNC showed significant improvement in respiratory rate, dyspnoea, ROX index, and PaO2/FiO2 ratio at 60 min, 120 min, and 24 h in all patients, including hypercapnic subgroups. The study concluded HFNC is an effective and safe alternative for elderly ARF patients not requiring ICU admission.", "population_specificity": "Elderly patients (mean age 83 years, predominantly women, obese, high comorbidity, mild-moderate dependence) with ARF not due to COVID-19.", "effective_dosage": "Not specified", "study_duration": "Evaluated at 60 min, 120 min, and 24 h", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:43.698396+00:00"}
{"study_id": 53137, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of artificial intelligence in improving the treatment of obstructive sleep apnea, including the use of Continuous Positive Airway Pressure.", "results_summary": "The study found that artificial intelligence can enhance OSA treatment by predicting outcomes, evaluating current treatments, and personalizing therapy based on individual mechanisms of the disease. Continuous Positive Airway Pressure was noted as effective when used with appropriate adherence, though compliance rates remain low.", "population_specificity": "Not specified (general OSA patients, based on reviewed literature).", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:45.921837+00:00"}
{"study_id": 53135, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the feasibility and outcomes of high nCPAP (9-15 cmH2O) versus NIPPV (target mean Paw 9-15 cmH2O) in preterm neonates <29 weeks' gestational age who fail traditional nCPAP or are extubated from invasive mechanical ventilation.", "results_summary": "The study is a pilot trial assessing feasibility for a larger definitive trial, with primary outcomes focused on recruitment rates and protocol violations. Secondary outcomes include treatment failure within 7 days and clinical outcomes like bronchopulmonary dysplasia, but results are not yet reported.", "population_specificity": "Preterm neonates <29 weeks' gestational age who fail traditional nCPAP or are extubated from invasive mechanical ventilation with mean airway pressure \u226510 cmH2O.", "effective_dosage": "High nCPAP (9-15 cmH2O) or NIPPV (target mean Paw 9-15 cmH2O).", "study_duration": "7 days post-randomization for primary failure outcome.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:46.278108+00:00"}
{"study_id": 53136, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining drug-induced sleep endoscopy (DISE) with CPAP titration could inform more appropriate pressure settings for treating moderate-to-severe obstructive sleep apnea (OSA).", "results_summary": "The study found that CPAP improved upper airway (UA) collapse in 90% of subjects at the velum and 75% at the oropharynx, though the mean 95th percentile CPAP titration pressure was often lower than the optimal pressure needed to alleviate collapse. The palate and lateral pharynx were more responsive to CPAP than the hypopharynx.", "population_specificity": "30 subjects with moderate-to-severe OSA (mean age 37.5, 17% women).", "effective_dosage": "CPAP pressure ranges of 5 to 25 cmH\u2082O.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:47.257703+00:00"}
{"study_id": 53138, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to review the current evidence and understanding of the relationship between obstructive sleep apnea and vitamin D deficiency, including potential mechanisms linking the two.", "results_summary": "The abstract does not provide specific findings about Continuous Positive Airway Pressure, as it focuses on the relationship between obstructive sleep apnea and vitamin D deficiency.", "population_specificity": "Not specified (abstract discusses a narrative review, not a specific study population).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:47.324056+00:00"}
{"study_id": 53139, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether treating obstructive sleep apnea (OSA) with continuous positive airway pressure (CPAP) improves exercise capacity in patients with pulmonary hypertension (PH) undergoing cardiac rehabilitation (CR).", "results_summary": "The study found that CPAP treatment for OSA was associated with greater improvement in exercise capacity (measured in METs) in patients with PH undergoing CR, but not in those without PH. Baseline PH was linked to lower initial exercise capacity, but CR-related improvements were not attenuated by PH status.", "population_specificity": "290 patients participating in cardiac rehabilitation, including 44 with pulmonary hypertension and 102 with known OSA (30 treated, 72 untreated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:50.311749+00:00"}
{"study_id": 53140, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness of Continuous Positive Airway Pressure (CPAP) and surgical interventions like aortopexy and posterior tracheopexy for treating tracheomalacia (TM) associated with esophageal atresia (EA) repair.", "results_summary": "CPAP is generally applied for TM treatment, but surgical interventions (aortopexy or posterior tracheopexy) are often required for severe cases. Most TM cases showed symptom improvement after aortopexy, suggesting vascular compression may contribute to TM.", "population_specificity": "Patients with tracheomalacia following esophageal atresia repair.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:50.769123+00:00"}
{"study_id": 53141, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the accuracy of CPAP machines' automatic respiratory event detection algorithms by comparing CPAP-determined apnea-hypopnea index (AHI) with reference standards.", "results_summary": "The meta-analysis found good clinical agreement in AHI measurements between CPAP machines and reference standards, with pooled mean biases and limits of agreement suggesting reliable performance, though variations existed between manufacturers.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:51.556675+00:00"}
{"study_id": 53146, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to examine the effectiveness of behavioral and psychosocial interventions on CPAP adherence in patients with Obstructive Sleep Apnea (OSA).", "results_summary": "Telemonitoring increased the mean nightly hour of CPAP use compared to standard care, and Motivational Enhancement Therapy (MET) had the most significant effect on long-term adherence.", "population_specificity": "Newly diagnosed patients with OSA, naive to CPAP treatment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:54.483135+00:00"}
{"study_id": 53145, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "To identify key technical aspects and nursing interventions for improving patient comfort during Helmet-CPAP treatment.", "results_summary": "The study identified nine key themes, including gas flow management and noise reduction, and proposed a Helmet-CPAP check-list to enhance patient comfort and treatment compliance.", "population_specificity": "Patients undergoing Helmet-CPAP treatment (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:54.726806+00:00"}
{"study_id": 53142, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the clinical applications and effectiveness of helmet-delivered CPAP compared to other noninvasive strategies in managing different phenotypes of acute respiratory failure.", "results_summary": "The study suggests that helmet CPAP may offer advantages in acute hypoxemic respiratory failure (AHRF) by enabling high positive end-expiratory pressure, potentially reducing self-inflicted lung injury, but its superiority over other methods remains unconfirmed. In AECOPD patients, helmet efficacy may be inferior to face masks, with caution advised due to CO2 retention risks.", "population_specificity": "Patients with acute respiratory failure, including AHRF and AECOPD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:55.784974+00:00"}
{"study_id": 53129, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the role of machine learning techniques in optimizing continuous positive airway pressure (CPAP) therapy for sleep-related breathing disorders.", "results_summary": "The study found that machine learning models showed promising results in optimizing CPAP therapy, including predicting treatment outcomes and improving diagnostic accuracy for sleep apnea.", "population_specificity": "Patients with sleep-related breathing disorders (e.g., obstructive and central sleep apnea).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:56.216521+00:00"}
{"study_id": 53143, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the use of PEEP in chronic care for children with upper airway abnormalities to address severe persistent obstructive sleep apnea.", "results_summary": "PEEP is increasingly used in children with upper airway abnormalities to manage obstructive sleep apnea, with improvements in equipment and interfaces allowing use at any age. However, validated criteria for initiation, optimal settings, follow-up, and weaning are lacking.", "population_specificity": "Children with anatomical or functional abnormalities of the upper airways, particularly those with severe persistent obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:56.337132+00:00"}
{"study_id": 53147, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of CPAP treatment on cognitive function in stroke patients with obstructive sleep apnoea (OSA) by analyzing randomized controlled trials.", "results_summary": "CPAP treatment did not significantly improve global cognition overall but showed significant benefits when initiated early (<2 weeks post-stroke). It also significantly reduced subjective sleepiness but had no significant effect on memory, language, attention, or executive function.", "population_specificity": "Stroke patients with obstructive sleep apnoea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:58.119536+00:00"}
{"study_id": 53148, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the relationship between sleep-disordered breathing (SDB) and retinal vessel diameters (CRAE and CRVE) and assess the effects of a cardiovascular risk factor minimization and CPAP intervention on these measures in severe OSA patients.", "results_summary": "The study found no major associations between SDB metrics and retinal vessel diameters in the main cohort, but the RFM/CPAP intervention reduced evening CRVE in severe OSA patients (AHI >30 events/hr). The implications for cerebrovascular disease risk remain uncertain.", "population_specificity": "Diabetes-free sleep clinic patients (n = 264, with a severe SDB subgroup of n = 85).", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:00.438139+00:00"}
{"study_id": 53149, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to investigate the prophylactic effect of continuous positive airway pressure (CPAP) in reducing cluster headache attacks in patients with chronic cluster headache.", "results_summary": "CPAP treatment did not significantly reduce the number of cluster headache attacks compared to sham treatment. One serious adverse event occurred during active treatment, but none during sham treatment.", "population_specificity": "30 participants (12 males, median age 49.5 years, range 20-66 years) with chronic cluster headache.", "effective_dosage": "Not specified", "study_duration": "Two months of active or sham CPAP treatment, preceded by a one-month baseline period and followed by a four-week washout period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:01.059017+00:00"}
{"study_id": 53150, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy of different surfactant treatment strategies (prophylactic vs. selective) for respiratory distress syndrome (RDS) in preterm infants, focusing on varying thresholds of FiO\u2082.", "results_summary": "The study found no statistically significant differences in neonatal mortality between infants treated with selective surfactant therapy at 30%, 40%, or 50% FiO\u2082 thresholds, suggesting no clear benefit of any specific threshold.", "population_specificity": "Preterm infants under 32 weeks of gestational age.", "effective_dosage": "Not specified (intratracheal surfactant, irrespective of type or dose).", "study_duration": "Not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:03.788998+00:00"}
{"study_id": 53151, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore why the treatment effect of CPAP/NIV in reducing bronchopulmonary dysplasia (BPD) is not larger and how early identification of preterm infants likely to fail CPAP/NIV could improve outcomes.", "results_summary": "The study found that CPAP/NIV reduces exposure to mechanical ventilation and rates of BPD, but the treatment effect could be enhanced by better targeting therapy and early identification of infants likely to fail CPAP/NIV. Less invasive surfactant administration may also improve outcomes when combined with CPAP/NIV.", "population_specificity": "Premature to extremely premature infants in neonatal intensive care units.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:03.802154+00:00"}
{"study_id": 53153, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy of inspiratory muscle training (IMT) in improving blood pressure and sleep-related outcomes in patients with obstructive sleep apnea (OSA).", "results_summary": "IMT significantly lowered systolic and diastolic blood pressure, plasma catecholamine levels, and improved sleep quality and daytime sleepiness scores, but did not significantly affect the apnea-hypopnea index or lung function measures. No adverse effects were reported.", "population_specificity": "160 patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:04.117206+00:00"}
{"study_id": 53154, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and multidisciplinary collaboration of rapid maxillary expansion (RME) treatment, including its combination with continuous positive airway pressure (CPAP), for pediatric obstructive sleep apnea (OSA).", "results_summary": "The study found that CPAP, when combined with RME and other treatments like adenotonsillectomy and mandibular advancement, can be more effective for recurrent or residual OSA in children. Recent clinical research supports a multidisciplinary approach to improve sleep-disordered breathing in pediatric patients.", "population_specificity": "Children with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:04.769491+00:00"}
{"study_id": 53152, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the correlation between paroxysmal slow wave events (PSWEs) and cognitive impairment in OSA patients and assess the impact of CPAP treatment on PSWEs after one year.", "results_summary": "CPAP treatment was associated with reduced PSWEs in OSA patients, suggesting a potential mechanism linking hypoxia-induced BBB dysfunction to cognitive impairment. PSWEs were positively correlated with serum biomarkers (CyPA and MMP-9) and may serve as a marker for cognitive impairment in OSA.", "population_specificity": "339 subjects with subjective snoring complaints, including OSA patients with and without mild cognitive impairment (MCI) and controls without OSA.", "effective_dosage": "Not specified", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:05.290225+00:00"}
{"study_id": 53155, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to determine whether bilevel positive airway pressure (BPAP) reduces the incidence of hypoxemia in patients with obstructive sleep apnea (OSA) or overweight status during sedated gastroscopy compared to nasal cannula.", "results_summary": "BPAP therapy significantly reduced the incidence of hypoxemia (from 40.0% to 2.5%), subclinical respiratory depression (from 52.5% to 22.5%), and severe hypoxemia (from 17.5% to 0%). It also decreased propofol dosage, operation time, and improved anesthesiologist satisfaction.", "population_specificity": "Patients aged 18-65 years with OSA or overweight status undergoing sedated gastroscopy.", "effective_dosage": "Not specified", "study_duration": "Duration of gastroscopy procedure (exact time not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:07.905970+00:00"}
{"study_id": 53157, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare alternative methods of surfactant delivery with the INSURE technique to reduce complications associated with mechanical ventilation in preterm infants.", "results_summary": "The study found that alternative surfactant delivery methods (laryngeal mask, thin intratracheal catheter, and aerosolized surfactant) showed promising results in reducing mortality, need for mechanical ventilation, and bronchopulmonary dysplasia compared to INSURE, though conclusive evidence for broader adoption is still lacking.", "population_specificity": "Preterm infants with respiratory distress syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:08.715182+00:00"}
{"study_id": 53156, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and side effects of liraglutide combined with Continuous Positive Airway Pressure (CPAP) in treating type 2 diabetes mellitus patients with severe obstructive sleep apnea.", "results_summary": "The study found that liraglutide combined with CPAP significantly reduced BMI, mean systolic blood pressure, and apnea hypopnea index (AHI), while improving minimum oxygen saturation compared to CPAP alone. No significant difference in side effects was observed between the groups.", "population_specificity": "Type 2 diabetes mellitus patients with severe obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:08.810945+00:00"}
{"study_id": 53160, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specify a study goal related to Continuous Positive Airway Pressure.", "results_summary": "The abstract does not report results related to Continuous Positive Airway Pressure.", "population_specificity": "The abstract mentions NAFLD patients with sleep apnea syndrome (SAS).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:10.300550+00:00"}
{"study_id": 53158, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of virtual consultations versus in-person consultations for managing CPAP therapy in adult patients with obstructive sleep apnoea/hypopnoea syndrome (OSAHS).", "results_summary": "The study found no significant difference in improvement in patient-reported sleepiness scores between virtual and in-person consultations, though both groups showed improvement. Virtual care modestly increased CPAP adherence and was less costly than in-person care in the trials reporting cost-effectiveness.", "population_specificity": "Adult patients with obstructive sleep apnoea/hypopnoea syndrome (OSAHS) (n=1823).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:12.346728+00:00"}
{"study_id": 53161, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the optimal timing for initiating Non-Invasive Respiratory Support (CPAP/NIV) in patients with moderate SARS-CoV-2-related ARDS to improve outcomes.", "results_summary": "Starting CPAP/NIV in moderate ARDS (P/F 101-200) reduced in-hospital mortality and hospitalization length compared to severe ARDS (P/F \u2264100), but initiating it at P/F >150 showed no additional clinical benefit.", "population_specificity": "Hospitalized patients with moderate SARS-CoV-2-related ARDS.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:12.610871+00:00"}
{"study_id": 53159, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of Continuous Positive Airway Pressure (CPAP) with mandibular advancement devices (MAD) and sham treatments on 24-h mean blood pressure, sleep quality, Apnea Hypopnea Index (AHI), and patient compliance in obstructive sleep apnea patients.", "results_summary": "CPAP showed significant AHI reduction compared to MAD, but results were unclear for sleep quality, patient compliance, and 24-h mean blood pressure. CPAP was more effective than MAD in reducing AHI, but the quality of evidence was very low to low for most outcomes.", "population_specificity": "Patients with obstructive sleep apnea (497 in MAD group, 239 in CPAP group, 274 in sham group).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:13.903698+00:00"}
{"study_id": 53162, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to compare the effects of early neonatal respiratory management (CMV/CPAP vs. HFOV) on pulmonary ventilation-perfusion matching in preterm infants with bronchopulmonary dysplasia (BPD).", "results_summary": "Infants treated with HFOV showed significantly better pulmonary V/Q matching (60.4%) compared to those treated with CMV/CPAP (45.8%) at near-term age. The study suggests HFOV may be more effective than CMV/CPAP for improving lung function in preterm infants with BPD.", "population_specificity": "Preterm infants diagnosed with BPD who required mechanical ventilation in the first week of life.", "effective_dosage": "Not specified", "study_duration": "Intervention duration not explicitly stated; follow-up assessment at median postmenstrual age of 37 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:15.109651+00:00"}
{"study_id": 53163, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the relationship between sleep apnea and congestive heart failure (CHF), including the role of Continuous Positive Airway Pressure (CPAP) as a treatment strategy.", "results_summary": "The abstract highlights CPAP as one of several treatment strategies for sleep-related breathing disorders, particularly in patients with CHF, but does not provide specific efficacy data for CPAP alone. It emphasizes the importance of early detection and treatment to reduce cardiovascular risks.", "population_specificity": "Patients with obstructive sleep apnea (OSA) and central sleep apnea (CSA), particularly those with or at risk of congestive heart failure (CHF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:17.018544+00:00"}
{"study_id": 53164, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to examine the role of a structured diet management plan on OSA severity, nocturnal oxygen indices, and subjective sleep parameters in patients using CPAP.", "results_summary": "The study found that a dietary management plan, when delivered through an educational program, reduced OSA severity (measured by apnea-hypopnea index), improved nocturnal oxygenation, and enhanced subjective sleep parameters when combined with CPAP use. However, the evidence was noted to be low, and further research is needed.", "population_specificity": "Patients with obstructive sleep apnea (OSA), particularly those with obesity.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:17.389899+00:00"}
{"study_id": 53165, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of non-invasive ventilatory support (NIV), including nasal continuous positive airway pressure (nCPAP), in preventing intubation and managing respiratory distress syndrome (RDS) in preterm infants.", "results_summary": "The study found that nCPAP is superior to mechanical ventilation for preventing death or bronchopulmonary dysplasia (BPD) in preterm infants with RDS, with a number needed to treat between 25 and 35. Various NIV methods, including nCPAP, were reviewed for their efficacy in primary and secondary ventilatory support.", "population_specificity": "Preterm infants with respiratory distress syndrome (RDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:17.893490+00:00"}
{"study_id": 53166, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the accuracy of residual apnea-hypopnea index (AHI) detection by an automatic CPAP device (prismaLine) against manually scored polysomnography (PSG) indices in patients with obstructive sleep apnea (OSA).", "results_summary": "The study found a high correlation between the device-detected residual AHI and manually scored PSG indices, indicating reliable automatic event detection. The device's data on leakage and adherence further supported its utility for CPAP therapy implementation and follow-up in OSA patients.", "population_specificity": "50 patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:19.260132+00:00"}
{"study_id": 53169, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether treating sleep disturbances, particularly with Continuous Positive Airway Pressure (CPAP), improves cognitive function over at least 12 weeks.", "results_summary": "The study found no significant treatment effect of CPAP on cognitive function, despite reducing daytime sleepiness. The interventions did not lead to cognitive enhancement in the studied population.", "population_specificity": "Adults with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "12 months or less", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:19.863407+00:00"}
{"study_id": 53168, "supplement_id": 1048, "safety_score": "75", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to compare the benefits and harms of nasal masks versus nasal prongs for delivering CPAP in preterm infants with or at risk of respiratory distress, focusing on treatment failure, nasal trauma, mortality, and other morbidity.", "results_summary": "The study found that nasal masks may reduce CPAP treatment failure and moderate-severe nasal injury compared to prongs, with little to no effect on mortality or pneumothorax risk. The evidence on bronchopulmonary dysplasia was very uncertain.", "population_specificity": "Preterm infants (less than 37 weeks' gestation) with or at risk of respiratory distress, predominantly 26 to 34 weeks' gestation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:21.618050+00:00"}
{"study_id": 53172, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the bidirectional relationship between epilepsy and obstructive sleep apnea and assess whether treating sleep apnea with Continuous Positive Airway Pressure (CPAP) improves seizure control in medically refractory epilepsy patients.", "results_summary": "The study suggests that CPAP treatment for obstructive sleep apnea may improve seizure control in patients with medically refractory epilepsy, potentially enhancing their quality of life. The abstract indicates an evolving understanding of the relationship between epilepsy, sleep, and sleep disorders like obstructive sleep apnea.", "population_specificity": "Medically refractory epilepsy patients with coexisting obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:23.568395+00:00"}
{"study_id": 53170, "supplement_id": 1048, "safety_score": "100", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the feasibility of a low-cost, non-electric bubble NIPPV device for newborns with moderate respiratory distress compared to bubble CPAP.", "results_summary": "The study found that bubble NIPPV was feasible and safe, with similar vital signs and Downes scores compared to bubble CPAP. No adverse events were reported, and all newborns survived to discharge.", "population_specificity": "Newborns with moderate respiratory distress (Downes score \u2265 3), weight > 1500 g, and gestational age > 32 weeks.", "effective_dosage": "Bubble CPAP (5-8 cm H2O) vs. bubble NIPPV (Phigh 8-10 cm H2O/Plow 5-8 cm H2O).", "study_duration": "4 hours per treatment (total 8 hours).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:23.707815+00:00"}
{"study_id": 53173, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) in treating pediatric obstructive sleep apnea, comparing traditional lab titration with home auto-CPAP titration.", "results_summary": "CPAP showed significant short-term benefits (improved behavior, focus, attention, and sleep) and long-term benefits (improved cardiovascular and metabolic health) when adhered to by children. Home auto-CPAP titration is becoming more accepted as an alternative to lab titration.", "population_specificity": "Children with obesity, genetic disorders, neuromuscular disorders, or congenital malformations who have obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:25.490507+00:00"}
{"study_id": 53174, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the relationship between obstructive sleep apnea (OSA) and neurologic conditions (stroke, cognitive decline, epilepsy, migraines) and assess improvements in these conditions following CPAP treatment.", "results_summary": "The abstract indicates that CPAP is the most commonly prescribed treatment for OSA and suggests that the study reviews literature on its potential benefits for neurologic conditions, though specific results are not detailed.", "population_specificity": "Individuals with obstructive sleep apnea (OSA) and associated neurologic conditions (stroke, cognitive decline, epilepsy, migraines).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:25.690969+00:00"}
{"study_id": 53175, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to identify and evaluate predictors of adherence to Continuous Positive Airway Pressure (CPAP) therapy.", "results_summary": "The study found that about half of CPAP-treated patients are adherent, with various factors (disease pathophysiology, clinical features, demographics, device-related variables, and psychological factors) statistically significant but their clinical meaningfulness unclear. Limited multiple regression analyses have been applied to compare these variables.", "population_specificity": "CPAP-treated patients (specific demographics not detailed).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:26.222934+00:00"}
{"study_id": 53176, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the pathophysiology of sleep-related hypoventilation and assess the feasibility of continuous positive airway pressure as a therapeutic option.", "results_summary": "The study found that continuous positive airway pressure can be an effective treatment for hypoventilation in conditions like obesity-hypoventilation syndrome and chronic obstructive lung diseases. It also briefly outlines noninvasive ventilation modes and settings for treating sleep-related hypoventilation disorders.", "population_specificity": "Patients with obesity-hypoventilation syndrome or chronic obstructive lung diseases (overlap syndrome).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:27.321419+00:00"}
{"study_id": 53177, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the basis for selecting the interface (nasal vs. oronasal masks) for treating obstructive sleep apnea with Continuous Positive Airway Pressure.", "results_summary": "The abstract suggests that nasal masks may be more effective than oronasal masks for treating obstructive sleep apnea with Continuous Positive Airway Pressure, though long-term adherence may vary based on interface characteristics.", "population_specificity": "Patients with obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:28.062949+00:00"}
{"study_id": 53178, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the cost-effectiveness of Continuous Positive Airway Pressure (CPAP) compared to alternative treatments for Obstructive Sleep Apnea (OSA).", "results_summary": "CPAP is identified as the gold-standard treatment for OSA and is cost-effective from both payer and societal perspectives. Alternative therapies like oral appliance therapy, surgeries, and hypoglossal nerve stimulation show less consistent cost-effectiveness results.", "population_specificity": "Individuals with Obstructive Sleep Apnea (OSA).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:29.828266+00:00"}
{"study_id": 53179, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to review the proven and likely clinical outcomes of Continuous Positive Airway Pressure (CPAP) treatment for obstructive sleep apnea.", "results_summary": "The study found that while CPAP is the most successful treatment for obstructive sleep apnea, demonstrating improvement in outcomes like daytime sleepiness and cardiovascular morbidity has been challenging due to difficulties in quantifying the illness and heterogeneity in patient presentations. The article reviews both proven and likely benefits of CPAP.", "population_specificity": "Patients with obstructive sleep apnea (no further specificity provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:31.659682+00:00"}
{"study_id": 53181, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the use of continuous positive airway pressure (CPAP) for managing respiratory distress in term newborns immediately after birth.", "results_summary": "The study found that CPAP is effective in managing respiratory distress in term newborns, supporting its use as a treatment recommendation. The evidence was reviewed systematically, and consensus was reached on its clinical application.", "population_specificity": "Term newborns experiencing respiratory distress immediately after birth.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:32.930475+00:00"}
{"study_id": 53182, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the influence of CPAP therapy on serum/plasma total antioxidant capacity (TAC) in patients with obstructive sleep apnea (OSA).", "results_summary": "CPAP therapy significantly increased TAC levels in OSA patients, with subgroup analyses confirming effectiveness across therapy duration, age, BMI, and AHI. Meta-regression indicated that CPAP's impact on TAC was associated with AHI, BMI, and age.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Varied (subgroup analysis based on therapy duration, but exact durations not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:34.309501+00:00"}
{"study_id": 53183, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to assess the feasibility and acceptability of bCPAP oxygen therapy for treating severe pneumonia and hypoxemia in children in low-resource hospital settings.", "results_summary": "The study identified structural and operational challenges (e.g., inadequate equipment, power disruptions) but found high satisfaction among clinicians and caregivers due to bCPAP's simplicity, effectiveness in easing breathing, and fast recovery without major adverse effects.", "population_specificity": "Children with severe pneumonia and hypoxemia in tertiary and general hospitals in Ethiopia.", "effective_dosage": "Not specified", "study_duration": "September 2019 to July 2020 (study duration); individual treatment duration not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:35.585034+00:00"}
{"study_id": 53184, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of Continuous Positive Airway Pressure (CPAP) on extracellular vesicle miRNA profiles in patients with severe obesity and obstructive sleep apnea (OSA).", "results_summary": "CPAP treatment for 6 months in patients with severe obesity and OSA led to significant decreases in miR21, miR126, and miR320, indicating a recovery outcome in extracellular vesicle miRNA profiles, while bariatric surgery showed no such effects.", "population_specificity": "Patients with severe obesity, divided into those with OSA (AHI > 10) and without OSA (AHI < 10).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:36.056306+00:00"}
{"study_id": 53185, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether upper airway radiofrequency tissue reduction under local anesthesia improves CPAP compliance and adherence in severe OSA patients.", "results_summary": "The study found significant improvements in AHI, arousal index, lowest SpO2, CPAP pressure, and CPAP usage time post-operatively, indicating better tolerance and adherence to CPAP.", "population_specificity": "Severe obstructive sleep apnea (OSA) patients using CPAP.", "effective_dosage": "Not specified", "study_duration": "Six months post last RF session", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:36.338161+00:00"}
{"study_id": 53186, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether continuous positive airway pressure (CPAP) influences lipid profiles (total cholesterol, triglycerides, LDL, and HDL) in patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found no significant correlation between CPAP use and changes in lipid profiles (TC, TG, LDL, HDL) in OSA patients, regardless of CPAP duration. The results contradict previous findings, suggesting a need for further validation in larger, long-term trials.", "population_specificity": "1,129 patients with obstructive sleep apnea (OSA) across 12 randomized controlled studies.", "effective_dosage": "Not specified", "study_duration": "Varied (subgroups: <12 weeks, =12 weeks, >12 weeks)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:40.439516+00:00"}
{"study_id": 53180, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) in managing respiratory failure in COVID-19 patients to prevent intubation.", "results_summary": "The study suggests that CPAP, along with other noninvasive respiratory support modalities, may help prevent intubation in COVID-19 patients with respiratory failure. It emphasizes the importance of supportive care in critically ill COVID-19 patients.", "population_specificity": "Critically ill COVID-19 patients with respiratory failure not requiring intubation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:42.176841+00:00"}
{"study_id": 53190, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "To determine if infants treated with nCPAP exhale through the CPAP system and to assess leakage during treatment.", "results_summary": "The study found that 32/50 infants exhaled through the CPAP system in at least one recording, and leakages exceeding 0.3 L/min were common (97/100 recordings). Measuring expiratory flows and leakages could optimize CPAP treatment.", "population_specificity": "50 infants with a mean gestational age of 34 weeks, median birth weight of 1948 g, and mean age at measurement of 6.5 days.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:43.478743+00:00"}
{"study_id": 53191, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of CPAP in critically ill children, comparing its efficacy with HFNC for respiratory support escalation (\"step up\") or post-extubation management (\"step down\").", "results_summary": "The study found that while initial randomized trials comparing CPAP and HFNC were inconclusive due to small sample sizes, the FIRST-ABC trials provided clearer insights into their efficacy. CPAP showed potential benefits in respiratory support, but findings were sometimes ambiguous or conflicting.", "population_specificity": "Critically ill children admitted to the PICU requiring respiratory support beyond simple oxygen therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:44.626260+00:00"}
{"study_id": 53192, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effectiveness of a disposable continuous positive airway pressure (DCPAP) system in reducing the partial pressure of carbon dioxide (PCO\u2082) in patients with respiratory distress.", "results_summary": "The study found a statistically significant difference in PCO\u2082 reduction between the DCPAP and non-DCPAP groups, suggesting that DCPAP provides a faster decrease in PCO\u2082 for patients with acute hypercapnic respiratory failure (AHRF).", "population_specificity": "Patients treated in the emergency department (ED) with respiratory distress and elevated PCO\u2082 (mean age 74.03 \u00b1 10.04, 23 male, 38 female).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:45.069497+00:00"}
{"study_id": 53193, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to validate the diagnostic potential of breath analysis for obstructive sleep apnea (OSA) and assess the metabolic differences between untreated OSA patients, OSA patients treated with continuous positive airway pressure (CPAP), and healthy subjects.", "results_summary": "The study confirmed 42 previously reported OSA markers in breath analysis, with nine markers significantly increased in untreated OSA compared to CPAP-treated patients. The OSA prediction model based on these markers achieved an AUC of 0.80, demonstrating moderate diagnostic accuracy.", "population_specificity": "Untreated OSA patients, CPAP-treated OSA patients, and healthy subjects (total n=118).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:45.213878+00:00"}
{"study_id": 53195, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of nasal pillows versus standard nasal masks for CPAP treatment in patients with obstructive sleep apnea (OSA).", "results_summary": "Nasal pillows and standard nasal masks were equally effective in terms of residual AHI levels and achieved similar therapeutic CPAP pressures. Nasal pillows showed slightly better CPAP adherence, though the clinical significance of this difference was questionable.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:50.177537+00:00"}
{"study_id": 53194, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to describe the technology and algorithms in PAP devices and review how different modes and comfort settings optimize therapy for sleep-disordered breathing.", "results_summary": "The abstract highlights the importance of understanding PAP device technology and selecting appropriate modes (e.g., CPAP, bilevel PAP) to optimize therapy, with descriptions derived from literature, manufacturer data, and clinical insights. It emphasizes the role of proprietary algorithms in controlling airflow and pressure.", "population_specificity": "Patients with sleep-disordered breathing (e.g., obstructive sleep apnea, central sleep apnea, sleep-related hypoventilation).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:52.301148+00:00"}
{"study_id": 53187, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to assess the effectiveness and safety of non-invasive positive pressure ventilation (NIPV), including Continuous Positive Airway Pressure (CPAP), for treating adults with central sleep apnoea (CSA).", "results_summary": "CPAP plus best supportive care may reduce central apnoea hypopnoea index (AHI) in CSA associated with chronic heart failure, but its impact on cardiovascular mortality and all-cause mortality remains uncertain. No adverse effects were observed with CPAP, though data on adverse events in control groups were often unreported.", "population_specificity": "Adults (>18 years) with central sleep apnoea, predominantly men (70-100%), many with chronic heart failure.", "effective_dosage": "Not specified", "study_duration": "Ranged from one week to 60 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:52.783137+00:00"}
{"study_id": 53188, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of CPAP in reducing mortality in children under 5 with severe pneumonia, focusing on implementation, effectiveness, and safety in low-resource settings.", "results_summary": "CPAP was found to be safe and effective, particularly for infants with bronchiolitis and children with pneumonia failing standard oxygen therapy, but requires intensive monitoring and supportive care. Mortality rates varied widely (0%-55%), and contextual factors like staffing and infrastructure were inconsistently reported.", "population_specificity": "Children aged 28 days to 4 years with pneumonia in low- or middle-income countries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:53.464574+00:00"}
{"study_id": 53196, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of an inspiratory muscle training (IMT) program on apnea and hypopnea index (AHI), inspiratory muscle strength, sleep quality, and daytime sleepiness in individuals with obstructive sleep apnea (OSA), with or without CPAP therapy.", "results_summary": "The study found that a 12-week IMT program significantly increased inspiratory muscle strength, reduced AHI, and improved sleep quality and daytime sleepiness in both CPAP users and non-users. The improvements were consistent across all measured parameters.", "population_specificity": "Individuals with obstructive sleep apnea (OSA), both CPAP users and non-users.", "effective_dosage": "IMT with a progressive resistive load of 40-70% of maximum inspiratory pressure (PImax) for 30 breaths once daily.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:53.876488+00:00"}
{"study_id": 45255, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether acute curcumin treatment influences cognitive function and underlying neural activity in mice.", "results_summary": "Acute curcumin treatment improved object recognition memory performance and enhanced delta oscillations in the hippocampus, suggesting a potential neuromodulatory effect for memory recognition.", "population_specificity": "Mice", "effective_dosage": "Not specified", "study_duration": "Acute (single administration)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:00.721121+00:00"}
{"study_id": 45249, "supplement_id": 1062, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the potential benefits of a curcumin-enriched diet as an adjunct therapy for adults with colorectal cancer, focusing on survival rates, quality of life, tumor reduction, and anti-inflammatory effects.", "results_summary": "Curcumin administration was associated with improved survival rates, enhanced quality of life, tumor reduction, and anti-inflammatory effects, though its limited bioavailability and gastrointestinal discomfort were noted challenges.", "population_specificity": "Adults with colorectal cancer.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:01.994822+00:00"}
{"study_id": 45250, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of curcumin on neuroinflammation and cognitive function in a rat model of febrile convulsions.", "results_summary": "Curcumin significantly reduced hippocampal TNF-\u03b1 levels, improved spatial memory performance, and shortened escape latencies and distances traveled in the Morris Water Maze test. It also reduced FC termination time, suggesting neuroprotective effects against febrile seizure-related neuroinflammation and cognitive dysfunction.", "population_specificity": "10-day-old male Wistar rat pups.", "effective_dosage": "200 mg/kg/day, administered intraperitoneally.", "study_duration": "Seven consecutive days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:02.618020+00:00"}
{"study_id": 45256, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers sought to determine whether combining \u03b3-VL and curcumin produces synergistic effects in reducing microglial activation and neuroinflammation.", "results_summary": "The combination of \u03b3-VL and curcumin synergistically reduced LPS-induced microglial activation, significantly inhibiting pro-inflammatory factors (IL-1\u03b2, TNF-\u03b1, NO) more effectively than either compound alone. The anti-inflammatory effects were linked to NLRP3 downregulation and modulation of the NOX2/Nrf2 pathway.", "population_specificity": "Primary rat cortical microglia", "effective_dosage": "Low micromolar concentrations (exact dosage not specified)", "study_duration": "Duration not explicitly stated", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:02.681792+00:00"}
